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ABSTRACT
Aflatoxin, a mycotoxin, is one of the world’s most potent carcinogen. It
contaminates major food products such as milk, grains, nuts, corn, etc., leading to greater
than $ 1 billion in economic losses and when ingested causes hepatocellular carcinoma
(HCC). It is the primary risk factor for 75% HCC cases in the developing world and 3%
HCC cases in developed world. Most common methods used in agriculture to reduce
aflatoxin contamination are expensive, time consuming and have low efficiency with
limited success rates where as biological controls were proven to be most effective in
inhibiting aflatoxins and aflatoxin producing fungi. Vibrio gazogenes, a non-pathogenic
gram-negative marine bacterium, was proven to synthesize antifungal and antiaflatoxin
metabolites. In this research study we have used Aspergillus parasiticus and Aspergillus
flavus – two saprophytic pathogenic fungi as aflatoxin-producing models. Preliminary
experimentation by treating V. gazogenes with aflatoxin produced aflatoxin responsive
metabolites (ARMs) that had the ability to significantly decrease aflatoxin synthesis by
inhibiting the aflatoxin genes (aflR, nor-1, ver-1) and global secondary metabolism genes
(LaeA, VeA). But the decrease in aflatoxin was only 40%. So we treated the fungal
cultures with the cells of V. gazogenes and the aflatoxin ELISAs revealed the significant
decrease (>99%) in aflatoxin biosynthesis by the fungi. The aflatoxin inhibitory effect
was very specific to V. gazogenes and not to other gram-positive or gram-negative
bacterium. Infecting corn kernels with A. flavus in the presence of bacterium significantly
decrease the fungal conidial growth by 50% and aflatoxin by 98%. Treating drosophila
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flies with V. gazogenes prior to A. flavus infection increased their survival. Using
confocal, scanning electron and transmission electron microscopies we observed the
uptake of the bacterium by the fungus into vesicles. RT-PCR assays revealed that live V.
gazogenes cells significantly up-regulate aflatoxin genes (aflR, nor-1, ver-1) and global
secondary metabolite genes (laeA, veA). The pathway through which V. gazogenes
inhibits aflatoxin is complicating. But our study had clearly developed a novel tool (V.
gazogenes) to inhibit the aflatoxin biosynthesis, which is acting at the cellular level rather
than at the gene level.
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CHAPTER 1
INTRODUCTION
1.1 AFLATOXINS
Aflatoxins are one of the most potent and dangerous carcinogens known
worldwide (Schmale and Munkvold, 1998). They were discovered in the 1960s when
100,000 turkeys died in Britain due to a toxin found in their peanut meal. The
investigation led to the discovery of toxins secreted by Aspergillus flavus (Negash, 2018).
The term aflatoxin is an acronym of Aspergillus flavus toxins (Brase S 2013). Aflatoxins
are low molecular weight molecules of secondary metabolism produced by fungi
belonging to the genus Aspergillus and Penicillium, during favorable growth conditions
of oxygen, moisture (>7%), warm temperatures (24-35oC) and substrate (sugar)
(Williams et al., 2004). Aflatoxins are a group of structurally related compounds
consisting of 5 rings – a furofuran moiety, an aromatic ring, a lactone ring and either a
pentanone or a lactone ring to complete the structure (Brase S 2013) (Figure 1.1). More
than 20 known aflatoxins exists of which aflatoxin B1 (AFB1), aflatoxin B2 (AFB2),
aflatoxin G1 (AFG1), aflatoxin G2 (AFG2) are the primary aflatoxins and aflatoxin M1
(AFM1) and aflatoxin M2 (AFM2) are the hydroxylated metabolites of AFB1 and AFB2
(Kumar et al., 2016).
According to the Chicago council on global affairs, 25% of all harvests in USA
are contaminated by mycotoxins of which aflatoxin contamination of corn alone causes
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losses at the high end of $1 billion (Mitchell et al., 2016). In the USA alone, the number
of samples tested positive for aflatoxin increased 6% from 2012 to 2013. The FDA limits
for aflatoxin human consumption is 20ppb, animal feeds is 300ppb and for aflatoxin M1
in milk is 0.5ppb (FDA 2011). Aflatoxins contaminate crops, produce, food, nuts, cereal,
milk, juices, homes, wood, etc., and can be ingested into intestines and enter systemic
circulation. Depending on the amount of dose and length of period of intake, aflatoxin
ingestion, inhalation or adsorption causes aflatoxicosis. Large doses for a short period of
time lead to acute illness - abdominal pain, vomiting, enlarged liver, liver damage, fever,
hemorrhage, pulmonary edema, digestive symptoms, convulsions etc. Chronic sub-lethal
doses lead to immunologic suppression, decreased nutritional uptake, decreased growth
and underweight in children and promoting liver cancers (Williams et al., 2004).
Aflatoxin B1 has been categorized as class 1A human carcinogen by the International
Agency of Research on Cancer (IARC) because it causes hepatocellular carcinoma. It is
projected that 25,200-155,000 cases of liver cancer worldwide are attributed to aflatoxin
exposure (Wu et al., 2011).
Aflatoxin undergoes biotransformation primarily in the liver of both human and
animal bodies producing a highly reactive epoxide that can bind to DNA, RNA, and
proteins altering mitochondria structures and electron transport, effecting cell division
and disrupting protein synthesis (Bbosa et al., 2013). Aflatoxin B1 can be passively
absorbed through the intestines and is further metabolized by cytochrome P-450
(CYP1A2, 3A4, 3A5, 3A7) enzymes in liver generating a mixture of metabolites of
which aflatoxin-8,9-epoxide is highly reactive forming DNA adducts that are capable of
GC to TA mutations inhibiting the tumor suppressor gene p53 (Bbosa et al., 2013) (Wu et
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al., 2011) (Gratz et al., 2007) (Carlos A. Muro-Cach 2004). This p53 mutation had been
observed in 30-60% of the liver cancers in aflatoxin-exposed cases. The reactive epoxide
also binds to proteins in liver inhibiting them causing significant cellular damaging and
acute aflatoxicosis in both humans and animals (REF). Aflatoxin also crosses placenta
and is metabolized by the fetal CYP450 liver enzymes producing the same highly
reactive epoxide. Thus aflatoxins are toxic, mutagenic, and carcinogenic (Bbosa et al.,
2013).
1.2 Aspergillus flavus and Aspergillus parasiticus
Aflatoxin is biosynthesized by many Aspergillus species such as A. flavus, A.
parasiticus,

A.

nominus,

A.

pseutotamarii,

A.

bombycis,

A.

toxicarius,

A.

parvisclerotigenus, A. minisclerotigenes, A. arachidicola, and A. pseudocaelatus. But
primarily aflatoxins are produced in copious amounts by A. flavus and A. parasiticus,
which can cohabit and flourish on practically any crop or food including but not limiting
to maize, oilseeds, spices, groundnuts, tree nuts, milk, and dried fruit (Strosnider et al.
2006) (Varga et al., 2011). Aspergillus can also synthesize aflatoxin during postharvest
handling of storage, transportation and food processing (Wu 2011).
Aspergillus parasiticus is a soil mold that was discovered in 1912 by a pathologist
A. T. Speare (Horn et al., 2009). It is a saprophyte, a plant pathogen and an opportunistic
pathogen to humans and animals and produces aflatoxins B1, B2, G1 and G2.
The fungus Aspergillus flavus is a saprophyte, growing in humid environments
with pathogenic ability causing aspergillosis in immuno-compromised humans effecting
the skin, oral mucosa and subcutaneous tissues (Hedayati, et al. 2007: 1677-92).
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According to the centers for disease control and prevention (CDC) approximately 4.8
million cases of aspergillosis were diagnosed worldwide and A.flavus is the second most
leading cause. A.flavus also infects corn, peanuts and cotton by releasing aflatoxins.
Aflatoxin B1, an A.flavus secondary metabolite, has been categorized as class 1A human
carcinogen by the International Agency of Research on Cancer (IARC) and contaminates
crops, produce, food, nuts, cereal, milk, juices, homes, wood, etc., and can be ingested
into intestines and enter systemic circulation causing aflatoxicosis and liver cancer.
Most A.flavus strains are susceptible to antifungal therapy but the minimum
inhibitory concentrations are atleast two fold higher than for other Aspergillus species
(Krishnan, et al. 2009: 206-22). Furthermore, recent discoveries revealed the presence of
active multi drug resistant genes in A.flavus strains increasing their potential for drug
resistance and pathogenicity (Tobin, et al. 1997: 11-23) (Van Der Linden, et al. 2011:
S82-9). Aflatoxin B1 synthesized by A.flavus is extremely stable and cannot be detoxified
by cooking or autoclaving and thus pollutes many food groups being ingested by humans
and animals.
1.3 Vibrio gazogenes
Most common methods used in agriculture to reduce aflatoxin contamination are
expensive, time consuming and have low efficiency with limited success rates. Novel
therapies are required to fight against A.flavus strains and inhibit both its pathogenicity
and aflatoxin production without affecting the host physiology. In their zeal to find new
anti-fungal and anti-aflatoxin agents scientists have turned towards plant and microbe
derived compounds especially from organisms that live in aflatoxin induced
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environments (Holmes, et al. 2008: 559-72). Vibrio gazogenes is a marine gram-negative
bacterium notoriously known for its synthesis of antifungal pigments. Studies have
shown that when V.gazogenes comes in contact with aflatoxin, the toxin induces
V.gazogenes to synthesize antifungal and anti-aflatoxin compounds (Gummadidala, et al.
2016: 814). Understanding the mechanism by which V.gazogenes decreases aflatoxin and
inhibits pathogenicity of A.flavus will help us further understand how to develop, design
and target A.flavus pathogen and decrease mortality rates of fungal infected patients and
plants. Similarly, fungal bacterial interactions can be used as model systems for
generation of new antifungals. Finally polymicrobial (bacterial and fungal) colonies pose
a potential problem in clinical setting given their multi-drug resistance capabilities,
understanding the molecular pathways that define the fungal bacterial interactions is an
important step towards discovering new therapeutic targets.
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Figure 1.1: Chemical structures of the primary 6 Aflatoxins: The lettering inside the
chemical structure of Aflatoxin B1 represents the various rings – A and B make up the
furofuran moiety, C is the aromatic ring, D is the lactone ring and E is either a pentone or
lactone ring
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CHAPTER 2
AFLATOXIN-EXPOSURE OF Vibrio gazogenes AS A NOVEL SYSTEM
FOR THE GENERATION OF AFLATOXIN SYNTHESIS INHIBITORS1

1Gummadidala PM, Chen YP, Beauchesne KR, Miller KP, Mitra C, Banaszek N,
Velez-Martinez M, Moeller PD, Ferry JL, Decho AW, Chanda A. Front Microbiol. 2016
Jun 3;7:814. Reprinted here with permission of publisher
7

2.1 ABSTRACT
Aflatoxin is a mycotoxin and a secondary metabolite, and the most potent known
liver carcinogen that contaminates several important crops, and represents a significant
threat to public health and the economy. Available approaches reported thus far have
been insufficient to eliminate this threat, and therefore provide the rational to explore
novel methods for preventing aflatoxin accumulation in the environment. Many terrestrial
plants and microbes that share ecological niches and encounter the aflatoxin producers
have the ability to synthesize compounds that inhibit aflatoxin synthesis. However,
reports of natural aflatoxin inhibitors from marine ecosystem components that do not
share ecological niches with the aflatoxin producers are rare. Here we show that a nonpathogenic marine bacterium, Vibrio gazogenes, when exposed to low non-toxic doses of
aflatoxin B1, demonstrates a shift in its metabolic output and synthesizes a metabolite
fraction that inhibits aflatoxin synthesis without affecting hyphal growth in the model
aflatoxin producer, Aspergillus parasiticus. The molecular mass of the predominant
metabolite in this fraction was also different from the known prodigiosins, which are the
known antifungal secondary metabolites synthesized by this Vibrio. Gene expression
analyses using RT-PCR demonstrate that this metabolite fraction inhibits aflatoxin
synthesis by down-regulating the expression of early-, middle- and late- growth stage
aflatoxin genes, the aflatoxin pathway regulator, aflR and one global regulator of
secondary metabolism, LaeA. Our study establishes a novel system for generation of
aflatoxin synthesis inhibitors, and emphasizes the potential of the under-explored
Vibrio’s silent genome for generating new modulators of fungal secondary metabolism.
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2.2 INTRODUCTION
Aflatoxins are a group of secondary metabolites that are synthesized primarily by
food-borne fungi such as Aspergillus parasiticus and Aspergillus flavus. These Aspergilli
contaminate a variety of economically important crops such as corn, wheat, peanuts, tree
nuts, dried fruits, vegetables, and medicinal plants in tropical and subtropical areas
worldwide (Trail et al., 1995, Bennett and Klich, 2003, Chanda et al., 2009, Georgianna
and Payne, 2009). Aflatoxin B1 is the most potent liver carcinogen known and its
contamination in food and feed is a significant risk factor of liver cancer risk in humans
and animals (CAST, 2003, Liu and Wu, 2010). With liver carcinomas already being the
third leading cause of cancer-related mortality worldwide, the global increase in
prevalence of hepatitis B virus (HBV) and immunocompromised population has
increased the risk of aflatoxin-induced liver cancer (Liu and Wu, 2010). The elimination
of aflatoxin accumulation in food and feed, therefore, is of primary importance for
reducing its global burden on public health and economy.
Common agricultural approaches used for prevention of aflatoxin contamination
in crops include use of fungicides, biocontrol agents and fungi-resistant plants, crop
rotation, choice of a plantation time that avoids the aflatoxin-conducive climatic
conditions, and control of environmental factors during post-harvest (Kabak et al., 2006,
Wu and Khlangwiset, 2010a, Wu and Khlangwiset, 2010b, Cary et al., 2011). However,
most of these strategies are expensive, time-consuming and have demonstrated limited
success. To complement these conventional strategies, the use of compounds and
extracts, collected from plants and microbes that share ecological niches with the
aflatoxin producers, are becoming increasingly popular (Holmes et al., 2008). Examples
9

of these natural compounds include a variety of naturally derived volatile compounds
(Greene-McDowelle et al., 1999, Zeringue, 2000, Roze et al., 2004, Roze et al., 2007,
Roze et al., 2011). Despite the significant efforts in discovering aflatoxin biocontrol
agents, over 55 billion people worldwide still suffer from uncontrolled exposure to
aflatoxin (Strosnider et al., 2006), resulting in an est. 25,200 to 155,000 liver cancer cases
globally (Liu and Wu, 2010). Chronic low-level exposure to aflatoxins and other
carcinogenic mycotoxins remains a serious health threat in the US (Kensler et al., 1992)
and it is estimated that children in rural areas of the southern US ingest ~40 µg aflatoxin
each day through contaminated food; a situation contributing to the significant rise in
aflatoxin-induced liver cancer cases (Stoloff, 1976, Van Rensburg, 1977). NIH statistics
indicate that 16,600 new cases of aflatoxin-induced liver cancer annually in the US
(Kensler et al., 2011). Therefore, the aflatoxin monitoring programs and the destruction
and/or decontamination of agricultural commodities, which are adopted to meet aflatoxin
levels imposed by regulations from US and Europe for food and feed, remain an
expensive and time-consuming process. Hence development of additional novel
methodologies and compounds for aflatoxin elimination is essential.
Vibrio gazogenes is an estuarine Gram-negative bacterium that is well-known for
its ability to synthesize industrially-relevant proteins such as amylases and proteases
(Ratcliffe et al., 1982) and bactericidal and fungicidal pigments, magnesidin A (Imamura
et al., 1994), prodigiosins and cycloprodigiosins (Allen et al., 1983). Previous studies
have also shown that random mutations in this bacterium with 1-methyl-3-nitro-lnitrosoguanidine expanded its metabolic output and activated the synthesis of additional
bactericidal prodigiosin-related pigments, norprodigiosin and propyl prodigiosin
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(Alihosseini et al., 2010). This prompted us to hypothesize that a portion of the
bacterium’s metabolic potential remains silent under normal growth conditions, and can
be activated by genetic and environmental perturbations. In this study, we conducted
alterations of metabolism in V. gazogenes through exposures to non-toxic doses of the
mycotoxin, aflatoxin. While aflatoxin B1 has been reported to bind to several probiotic
bacteria (Kabak et al., 2009) and has also demonstrated the ability to alter
bioluminescence responses in V. fischeri (Li et al., 2011), there remains a lack of
understanding on how interaction of aflatoxin B1 or other mycotoxins affect fundamental
bacterial cell biology. To our surprise, aflatoxin exposure to V. gazogenes diminished
prodigiosin release into the growth medium, but additionally resulted in the production of
a new compound that demonstrated the ability to specifically-inhibit aflatoxin synthesis
in the model aflatoxin producer, A. parasiticus. Here we report the findings of this study.
We establish a novel system for generation of aflatoxin-inhibitors and provide a new
avenue in our fundamental understanding of Vibrio cell biology.
2.3 MATERIALS AND METHODS
2.3.1 Strains, media, and growth conditions
A. parasiticus, SU-1 (ATCC 56775), a wild-type aflatoxin producer. The strain
was grown on 100 mm petri dishes containing potato dextrose agar for 2 weeks. Fresh
spores collected from these colonies were used for all the experiments in this study that
involved the use of SU-1. In these experiments the fungus was grown in aflatoxininducing yeast-extract-sucrose (YES); a rich growth medium (containing 2% w/v yeast
extract, 6% w/v sucrose, pH 5.8), by inoculation of 104 spores per mL of liquid medium
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and incubated in the dark (29°C; shaking at 150 rpm). The bacterium Vibrio gazogenes
ATCC 43942 (Farmer, Hickman-Brenner et al. 1988), that was originally isolated from
sea water, was grown in Difco Marine Broth 2216 (BD Biosciences, Sparks, MD) at
28°C in a shaking incubator (190 rpm).
2.3.2 Growth measurements of A. parasiticus and V. gazogenes
All

fungal

growth

quantifications

were

performed

using

dry

weight

measurements. Briefly, the mycelia were filtered out of the growth media using a
miracloth (Millipore, Billerica, MA) and dried at 75°C for 6 hrs and the final weight was
recorded. All Vibrio growth measurements were performed using absorbance readings of
growth media at 600 nm.
2.3.3 Aflatoxin exposure experiments, extraction and analysis of Vibrio metabolites
Aflatoxin B1 was commercially obtained (Sigma). Three different doses (0.1, 0.2,
or 0.3 µg/mL) of aflatoxin B1 were added to the Vibrio growth medium at the start of the
culture. In the control flask only the vehicle (70% Methanol) was added. To extract the
metabolites from V. gazogenes the cells were first harvested by centrifugation and
extracted with 60 mL acetone. A portion of the filtrate was concentrated by evaporation
under N2 gas. The concentrate was loaded onto a silica gel column (1.2 x 15 cm) and
eluted with dichloromethane : methanol (80:1.5). The fractions were then purified on a
silica gel column using chloroform and methanol (50:2). After purification the fractions
were concentrated by evaporation under N2 gas and re-suspended in 1 mL methanol for
spectral analysis.
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2.3.4 ARMs exposure experiments and aflatoxin comparisons
Comparative semi-quantitative estimations of accumulation of aflatoxin in growth
medium was performed using thin layer chromatography (TLC) of the growth medium as
described previously (Banerjee, Gummadidala et al. 2014)
2.3.5 Total RNA purification and transcript analysis
Isolation of total RNA from fungal cells exposed to aflatoxin response
metabolites from V. gazogenes was performed using 30h old cultures. This is a time point
that corresponds to the activation of secondary metabolism (hence the expression of
aflatoxin genes in A. parasiticus) under the growth conditions adopted in this study
(Roze, Arthur et al. 2007). Purification of total RNA and preparation of complementary
DNA was performed as described previously (Chanda, Roze et al. 2009). Transcript
levels were quantified by performing quantitative real-time PCR assays using
SsoAdvanced universal SYBR Green supermix (BioRad Laboratories, Hercules, CA) and
gene-specific forward and reverse primers (Table 2.1) that were designed using Primer3
online software (http://www.ncbi.nlm.nih.gov/tools/primer-blast/). Reactions were
performed in a CFX96 thermal cycler (Bio-Rad Laboratories, Hercules, CA). As
described for previous gene expression studies in A. parasiticus (Roze, Arthur et al. 2007,
Chanda, Roze et al. 2009), expression value of each gene was obtained from the
threshold cycle values were normalized against β-tubulin (the house keeping gene) in
each sample. All RT-PCRs were performed in triplicates for each gene per sample. Data
analyses were performed using CFX Manager software (Bio-Rad Laboratories).
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2.3.6 Statistical analysis
All statistical tests were performed using GraphPad Prism Software (GraphPad,
CA, USA). Statistical analyses to determine for statistical significance of differences
between control versus experimental groups were determined using one-way ANOVA
(with sample size 3). An unpaired t-test was used to determine the gene expression
effects of ARMs on A. parasiticus compared to the untreated samples. Significance was
set at p<0.05.
2.4 RESULTS
2.4.1 Aflatoxin B1 exposures do not inhibit V. gazogenes growth
As a first step in understanding how V. gazogenes, responds to aflatoxin B1, we
investigated the effect of three different doses of aflatoxin B1 on the growth of V.
gazogenes. The doses, 10 ppb, 30 ppb and 50 ppb were either below, approximately equal
to or 5-fold higher than the highest-allowed aflatoxin level (20 ppb) in food and feed
(Mazumder and Sasmal 2001, CAST 2003 , Liu and Wu 2010). Time-course absorbance
readings were recorded to compare the growth rates of V. gazogenes, in presence of
aflatoxin B1, with untreated-controls. As shown in figure 2.1, none of the aflatoxin B1
doses demonstrated any significant effect on the growth of V. gazogenes.
2.4.2 Aflatoxin B1 exposures do not inhibit prodigiosin synthesis
Next, we investigated the effect of aflatoxin B1 exposures on the production of
prodigiosins by V. gazogenes. The prodigiosin fraction was obtained from cells (either
untreated control cells or cells exposed to aflatoxin B1) using our optimized laboratory
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protocol (see methods). Since the prodigiosins exhibit an absorbance peak at 530 nm
(figure 2.2a), this wavelength was used to compare prodigiosin levels between
experimental treatments and controls at three different time-points of growth (12h, 18h
and 42h). Our results (figure 2.2b) demonstrated that although cells exposed to aflatoxin
B1 showed a minor increase in absorbance values compared to the untreated samples, the
difference was not statistically significant.
2.4.3 Additional V. gazogenes metabolite fraction obtained by bacterial exposure to
aflatoxin B1: aflatoxin response metabolites (ARMs)
While growth and prodigiosin production by V. gazogenes was not affected in
presence of aflatoxin B1, we observed that exposure to aflatoxin B1 resulted in a distinct
alteration of color in the growth medium (figure 2.3a) suggesting the presence of a
different metabolite compared to untreated cells. Based on the ‘blue-shift’ in color of the
growth medium (bright red to orange) upon addition of aflatoxin B1, we hypothesized
that the bacterium synthesizes an additional metabolite fraction under these conditions
with a corresponding absorbance lower than that of the prodigiosin fraction. To test this,
we performed UV-Vis spectral analysis on the metabolite fractions of aflatoxin B1-treated
samples. The Vibrio metabolite fractions obtained from aflatoxin B1 treated samples
revealed a new absorbance peak at 470 nm, in addition to the prodigiosin peak at 530 nm
(Figure 2.3b). This suggested that aflatoxin B1 exposure affects the cellular metabolism of
V. gazogenes resulting in a different metabolite profile, compared to the untreated
control. Here, we denote this additional metabolite fraction in response to aflatoxin B1
exposure as ‘aflatoxin response metabolites (ARMs)’.
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2.4.4 ARMs do not inhibit A. parasiticus growth but inhibits aflatoxin synthesis
Next we proceeded to investigate whether ARMs affect the aflatoxin synthesis in
the model aflatoxin B1 producer, A. parasiticus. The activation of ARM production by
Vibrio occurred upon addition of aflatoxin B1 to their growth medium. Therefore, we
envisioned this alteration of metabolite profiles as a defensive response from Vibrio cells.
We hypothesized that ARMs will have a specific inhibitory effect on aflatoxin synthesis
in the producer cells. To test this we studied the growth and aflatoxin production by A.
parasiticus in presence of two different doses of the ARMs metabolite fraction (1 µg and
2 µg per mL of growth medium); the doses were chosen arbitrarily. To compare the
levels of aflatoxin biosynthesis in A. parasiticus exposed to ARMs exposed with the
untreated cells, we adopted a semi-quantitative approach in which we compared the
intensities of aflatoxin B1 and aflatoxin B2 bands on the thin-layer chromatography (TLC)
plates (see methods). As predicted, our TLC results generated from 40h cultures of A.
parasiticus, demonstrated that ARMs applied at the concentration of 2 µg per mL of
growth medium inhibited both aflatoxin B1 and aflatoxin B2 by approximately 2-fold
(figure 2.4a). Since the drop in aflatoxin synthesis could also have resulted from the
inhibition of A. parasiticus growth, we next compared the dry-weights of the A.
parasiticus mycelia exposed to 1 and 2 µg per mL of ARMs extract with the untreated
control mycelia. As shown in figure 2.4b, addition of ARMs to the growth medium did
not result any significant change in A. parasiticus dry weight, suggesting that inhibition
of aflatoxin synthesis in A. parasiticus by ARMs was a direct effect and not a growth
dependent effect.

16

2.4.5 ARMs metabolite fraction displays a different HPLC trace compared to prodigiosin
fraction
Our UV-Vis spectral analysis suggested that ARMs were synthesized by V.
gazogenes upon exposure to aflatoxin. We then proceeded to confirm that this fraction
(peak absorbance at 470 nm) was composed of metabolites of molecular masses that are
different from the Vibrio’s prodigiosin fraction (peak absorbance at 530 nm). As shown
in figure 2.5, HPLC traces showed that the prodigiosin fraction predominantly
demonstrated the expected molecular weight of 324 D, corresponding to the known
prodigiosin. The HPLC trace of ARMs on the contrary was clearly different, with a
predominantly displayed molecular mass 232 D, which demonstrate that the metabolite
fraction of ARMs was chemically different from the Vibrio’s prodigiosin fraction. These
results suggest that the differential metabolite profile in response to aflatoxin exposure
can occur either due to synthesis of new metabolites by V. gazogenes or due to
breakdown of prodigiosins resulting in novel smaller molecules with aflatoxin synthesis
inhibitory activity.
2.4.6 ARMs inhibit A. parasiticus aflatoxin biosynthesis at the level of transcript
accumulation
The fungal growth and aflatoxin results then prompted us to investigate whether
aflatoxin biosynthesis was inhibited at the level of transcript accumulation of aflatoxin
genes. To conduct this analysis we performed a quantitative comparison of transcript
accumulation of two genes nor-1, and ver-1 that encode two enzymes, Nor-1, Vbs and
Ver-1 respectively involved in the aflatoxin biosynthetic pathway (Chanda, Roze et al.
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2009). Activation of these genes in A. parasiticus occurs at 24h, and transcripts of all
aflatoxin enzymes accumulate by 30h, when the fungus is grown in YES growth medium
(Roze, Arthur et al. 2007). Hence we chose to examine the effects of ARMs extract on A.
parasiticus at three different time-points, 24h, 30h and 40h, a time-point when aflatoxin
is synthesized by the fungus at peak levels (Roze, Arthur et al. 2007). In addition to these
genes, we also compared the transcript accumulation of the aflatoxin pathway regulator,
aflR, at the same time points. As shown in figure 2.6, nor-1, ver-1 as well as the aflR
genes transcript levels demonstrated ≥5 fold reduction in presence of ARMs extract
compared to the vehicle control by 30h. Hence, our results suggest that ARMs extract
reduces aflatoxin synthesis at the level of transcript accumulation.
2.4.7 ARMs inhibit transcript accumulation of the secondary metabolism global
regulator, laeA but not veA
Since the regulatory network of the aflatoxin biosynthesis pathway is integral to
the global network of secondary metabolism in A. parasiticus as described in a recent
review by Brakhage (Roze, Arthur et al. 2007), we also proceeded to investigate whether,
ARMs target the global regulation of secondary metabolism. One key global regulatory
complex of fungal secondary metabolism is the VeA complex (Bayram, Krappmann et al.
2008). Central to this complex is the cross-talk between the two global regulators, LaeA,
a methyltransferase that is key to the epigenetic regulation of aflatoxin biosynthetic
pathway (Bok and Keller 2004), and VeA, a light responsive regulator that migrates from
cytoplasm to the nucleus in absence of light to form the VeA complex with LaeA and
other components in the complex (Bayram, Krappmann et al. 2008). In this study we
investigated whether ARMs affect transcript accumulation of either laeA or veA genes.
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To our surprise we found that, while no significant changes occurred in veA transcripts,
the laeA transcript accumulation was reduced by ~2 fold by 30h and ~4 fold by 40h
(figure 2.7), suggesting that ARMs inhibit aflatoxin biosynthesis at least in part, through
inhibition of LaeA.
2.5 DISCUSSION
Here we demonstrate the feasibility of a novel system for generation of aflatoxin
biosynthesis inhibitors, a concept that is analogous to the generation of antibodies upon
antigen exposure. Our data reveal that the estuarine bacterium V. gazogenes, upon
aflatoxin exposure, produces a metabolite profile that is chemically different from
untreated-cells. Upon isolation of the ARMs and applying them on the aflatoxin producer
cells, we found that the metabolites inhibit aflatoxin biosynthesis at the levels of
transcript accumulation. Based on our current study we propose two possible
explanations underlying this inhibition (illustrated in the schematic in figure 2.7). One
possible mechanism of inhibition is through the regulation of the laeA gene activation.
The laeA transcripts dropped by 2-4 fold during 30h to 40h time points suggesting that
ARMs inhibit the formation of the Velvet complex, a protein complex comprising LaeA
protein that regulate fungal secondary metabolism (Bayram, Krappmann et al. 2008).
Alternatively, it is also possible that in addition to laeA mediated inhibition ARMs inhibit
the activation of aflatoxin genes directly. Fungal growth was not inhibited during the
ARMs-mediated inhibition of aflatoxin biosynthesis, suggesting that the metabolites
target secondary metabolism specifically. Future studies will identify the molecule(s)
within ARMs that results in the aflatoxin inhibition. From our current preliminary
studies, we postulate that two or more compounds generated in response to aflatoxin
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exposure act either complementarily or synergistically to inhibit aflatoxin synthesis
inhibition. These collaborative effects will be determined in those functional
characterization studies with the purified compounds.
It is important to emphasize that specific aflatoxin inhibitory natural products that
have been characterized to-date were reported primarily from terrestrial organisms whose
ecological domains likely overlap with those of the aflatoxin producers. Examples
include natural products and volatiles from plants (Cleveland, Carter-Wientjes et al.
2009, Roze, Koptina et al. 2011, Chitarrini, Nobili et al. 2014), fungi (Ono, Sakuda et al.
1997, Yoshinari, Noda et al. 2010, Hua, Beck et al. 2014) and bacteria (Jermnak,
Chinaphuti et al. 2013, Wang, Yan et al. 2013, Kong, Chi et al. 2014). Our study provides
the first evidence, to the best of our knowledge, of an organism that demonstrates the
ability of synthesizing aflatoxin inhibitors, while not sharing ecological niches with
aflatoxin producers at all. Also this is the first report, to the best of our knowledge, of a
Vibrio-producing metabolite(s) that specifically inhibit aflatoxin biosynthesis without
affecting fungal growth. It is possible that mycotoxin triggered synthesis of mycotoxin
inhibitors is a phenomenon that is conserved in the Vibrio species. Alternatively, it is also
possible that Vibrio gazogenes is a chemically-gifted organism that has genetically
evolved with the rising mycotoxin levels in the environment with global changes in
climate (Kolpin, Schenzel et al. 2014, Rangel, Alder-Rangel et al. 2015).
The effect of ARMs mediated down-regulation of laeA gene, but not veA gene
suggests that the metabolites target cellular signaling receptors that specifically regulate
laeA gene expression. Since LaeA is a global regulator of secondary metabolism and
influences several mycotoxin biosynthetic pathways (Keller, Turner et al. 2005), we
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anticipate that aflatoxin inhibitor within ARMs will inhibit other mycotoxins as well.
Hence, for our follow-up studies we will categorize these as secondary metabolism
specific inhibitors instead denoting these as specific inhibitors against aflatoxin
biosynthesis.
Current investigations in our laboratory reveal that other fungal secondary
metabolites trigger synthesis of metabolite fractions in V. gazogenes that demonstrate
different HPLC traces compared to either prodigiosins or ARMs fractions. These results
implicate the need to examine the regulation of Vibrio genes under different
environmental signals. It appears from our studies that many areas of the Vibrio genome
remain silent under standard laboratory growth conditions and can be activated as needed
to generate metabolites that are relevant to the public health. Our future studies will shed
light on these silent areas of the V. gazogenes genome that encode the biosynthesis of the
secondary metabolism modulatory metabolites; the knowledge will enable us to clone
these areas on plasmids and engineer them as needed with the goal of purifying these
compounds in large quantities.

21

Table 2.1: List of PCR primers used for this study
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Figure 2.1: Effect of Aflatoxin B1 exposure on Vibrio gazogenes growth: Growth
comparisons were performed using comparisons of 600 nm absorbance values between
untreated V. gazogenes cultures and cultures were supplemented with 10, 30, and 50 ppb
of aflatoxin B1. Statistical significance of two-tailed p-values were determined using an
unpaired t-test with sample size of 3 and significance set as p < 0.05.
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Figure 2.2: Effect of aflatoxin B1 exposure on prodigiosin production: (A) UV-Vis
spectral profile of a prodigiosin-rich metabolite fraction demonstrating peak absorbance
at 530 nm. (B) Comparison of absorbance values at 530 nm, of methanol extracts from
untreated V. gazogenes cultures and cultures were supplemented with 10, 30, and 50 ppb
of aflatoxin B1. Statistical significance of two-tailed p-values were determined using an
unpaired t-test, with n=3, and p < 0.05 as significance level.
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Figure 2.3: Aflatoxin-response metabolites (ARMs) produced by the bacterium V.
gazogenes during exposure to aflatoxin B1 (AFB1). (A) Representative flasks
demonstrating the differences in appearance of untreated V. gazogenes cultures and the
aflatoxin B1 supplemented cultures. (B) Comparison of UV-Vis profiles of the methanol
extracts from untreated and supplemented V. gazogenes cultures.
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Figure 2.4: Effect of ARMs on aflatoxin biosynthesis and fungal growth. (A) Effect on
aflatoxin accumulation in the growth media: Left panel, a representative TLC plate
providing a qualitative comparison of aflatoxin accumulation in the untreated culture and
cultures that were supplemented with 1 and 2 µg/mL ARMs extract and the vehicle
(DMSO). Right panel, semi-quantitative comparative comparisons of band intensities of
aflatoxin B1 and aflatoxin B2. a, significant difference in band intensity compared to the
vehicle control. (B) Effect on growth: Comparison of dry-weight measurements. Bars
represent measurements relative to the dry-weight of untreated cells. Statistical
significance of two-tailed p-values were determined using an unpaired t-test, with sample
size of n = 3 and p < 0.05 set as level of significance.
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Figure 2.5: Comparison of HPLC traces of ARMs extract and the prodigiosin fraction of
V. gazogenes.
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Figure 2.6: Effects of ARMs on Aspergillus parasiticus gene expression. (A) Comparison
of transcript accumulation of aflatoxin-synthesis regulatory genes in A. parasiticus.
mRNA levels for each gene were observed at 24 h (aflatoxin synthesis start point), 30 and
40 h time points (aflatoxin synthesis is activated and reaches peak levels by 40 h). Black
bars, cells grown in presence of ARMs (2 µg/mL), Gray Bars, DMSO (vehicle) control.
(B) Comparison of transcript accumulation of two global regulators of secondary
metabolism, veA and laeA at the same time-points. Statistical significance of difference in
transcript accumulation between control and ARMs-treated cells were determined using
an unpaired t-test with sample size of 3 and two tailed p < 0.05 set as level of
significance. a, p < 0.05.
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Figure 2.7: Schematic representation of the inhibitory effect of ARMs on aflatoxin
biosynthesis: Current study demonstrates that ARMs inhibit aflatoxin biosynthesis in A.
parasiticus at the level of gene expression. We hypothesize that the inhibition of aflatoxin
genes as exemplified by the decreased nor-1, ver-1, and aflR transcripts in presence of
ARMs can be the effect of one or both of the following: (1) inhibition of laeA expression,
which in turn can have inhibitory impact on the activation of the aflatoxin genes, or (2) a
dual inhibition caused by direct inhibition on aflatoxin gene cluster activation along with
a laeA mediated inhibition. Red dotted arrows, regulatory roles established in previous
studies, red solid lines, inhibitory effect, gray curved arrows, gene activation, gray solid
line, schematic of the aflatoxin gene cluster showing relative positions of nor-1, ver-1,
and aflR in the cluster, brown solid line, laeA gene.
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CHAPTER 3
COMPLETE GENOME SEQUENCE OF Vibrio gazogenes ATCC 439421

1

Gummadidala PM, Holder ME, O'Brien JL, Ajami NJ, Petrosino JF, Mitra C, Chen YP,
Decho AW, Chanda A. Genome Announc. 2017 Jul 27;5(30). Reprinted with permission
from publisher.
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3.1 ABSTRACT
Vibrio gazogenes ATCC 43942 has the potential to synthesize a plethora of
metabolites in response to environmental triggers, which are of clinical and agricultural
significance. The complete genomic sequence of Vibrio gazogenes ATCC 43942 is
reported herein contributing to the knowledgebase of strains in the Vibrio genus.
3.2 INTRODUCTION
Vibrio gazogenes is an estuarine Gram-negative bacterium that is known for its
ability to synthesize industrially relevant proteins such as amylases and proteases
(Ratcliffe, Sanders et al. 1982), and bactericidal and fungicidal pigments, magnesidin A
(Imamura, Adachi et al. 1994), prodigiosins, and cycloprodigiosins (Allen, Reichelt et al.
1983).
V. gazogenes ATCC 43942 was recently studied by our laboratory for its response
to aflatoxin, a hepatocarcinogen and a mycotoxin that is produced from a group of
filamentous fungi under the genus Aspergilli. The bacterium demonstrated the ability to
generate a group of metabolites (named aflatoxin response metabolites, denoted as
ARMs) that were able to inhibit aflatoxin synthesis in the aflatoxin producer, Aspergillus
parasiticus (Gummadidala, Chen et al. 2016). Also, in our ongoing (unpublished) studies,
we have consistently observed the ability of this Vibrio strain to degrade mycotoxins and
generate a unique set of antibiotics that are active against multiple antibiotic resistant
bacterial strains. These observations prompted us to categorize this bacterium as
clinically and agriculturally significant, and have provided the rationale for sequencing its
genome.
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Genomic DNA extraction (10 – 20 µg) was performed using PureLink genomic
DNA minikit (Invitrogen). The extracted DNA was quantified using Nanodrop 1000
(Thermo Scientific) and quality of the DNA was assessed by running a 1% agarose gel
with the DNA gel stain SYBR safe (Life Technologies) and visualized in a ChemiDoc
MP system (Bio-Rad). DNA sequencing was performed on the Pacific Biosciences RS II
platform. One SMRT cell, yielding 73,434 post-filtered polymerase reads and having an
N50 read length of 26,245 bases and a mean read length of 16,358 bases, was used for
assembly in Pacific Biosciences’s SMRT Analysis v2.3.0 package using the
RS_HGAP_Assembly.2 protocol5. Quiver was subsequently used to polish the assembly.
The finished genomic sequences were annotated with NCBI’s Prokaryotc Genome
Annotation Pipeline. A high-quality finished version of the V. gazogenes genome is
reported here as two circular chromosomes and one circular plasmid with a mean
coverage of 185x with features as follows:
(1) Chromosome 1 (denoted as Chr_1): size 3,471,064 bp; GC% 45.5; proteins
2,988; rRNA 25; tRNA 87; ncRNA 4; Genes 3153; Pseudogenes 49,
(2) Chromosome 2 (denoted as Chr_2): Chr_2; size 1,303,572 bp; GC% 44.9;
proteins 1,102; tRNA 4; Genes 1,138; Pseudogenes 32, and
(3) Plasmid (denoted as P_1): size 11,916 bp; GC% 45.2; proteins 22; Genes 23;
Pseudogene 1.
The utility of prodigiosins that are synthesized by V. gazogenes ATCC43942
coupled with its ability to produce unique antibiotics and mycotoxin inhibitors under
custom designed environmental settings make this strain ‘chemically gifted’. In this
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context, its finished genomic sequence provides a necessary point of comparison with
other V. gazogenes strains and bacterial species within the Vibrio genus for elucidation of
the molecular factors that govern its unique metabolic profile.
3.3 Nucleotide sequence accession numbers(s)
The sequence of V. gazogenes ATCC 43942 has been deposited in NCBI
GenBank under the accession no(s) that are as follows: CP018835, CP018836 and
CP018837.
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CHAPTER 4
ACTIVATION OF AFLATOXIN BIOSYNTHESIS ALLEVIATED
TOTAL ROS IN Aspergillus parasiticus1

1

Kenne GJ*, Gummadidala PM*, Omebeyinje MH, Mondal AM, Bett DK, McFadden S,
Bromfield S, Banaszek N, Velez-Martinez M, Mitra C, Mikell I, Chatterjee S, Wee J,
Chanda A.Toxins (Basel). 2018 Jan 29;10(2). *Co-first authors. Reprinted with
permission from publisher.
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4.1 ABSTRACT
An aspect of mycotoxin biosynthesis that remains unclear is its relationship with
the cellular management of reactive oxygen species (ROS). Here we conduct a
comparative study of the total ROS production in the wild-type strain (SU-1) of the plant
pathogen and aflatoxin producer, Aspergillus parasiticus, and its mutant strain, AFS10, in
which the aflatoxin biosynthesis pathway is blocked by disruption of its pathway
regulator, aflR. We show that SU-1 demonstrates a significantly faster decrease in total
ROS than AFS10 between 24 h to 48 h, a time window within which aflatoxin synthesis
is activated and reaches peak levels in SU-1. The impact of aflatoxin synthesis in
alleviation of ROS correlated well with the transcriptional activation of five superoxide
dismutases (SOD), a group of enzymes that protect cells from elevated levels of a class of
ROS, the superoxide radicals (O2−). Finally, we show that aflatoxin supplementation to
AFS10 growth medium results in a significant reduction of total ROS only in 24 h
cultures, without resulting in significant changes in SOD gene expression. Our findings
show that the activation of aflatoxin biosynthesis in A. parasiticus alleviates ROS
generation, which in turn, can be both aflR dependent and aflatoxin dependent.
4.2 INTRODUCTION
Filamentous fungi synthesize and release a diverse array of secondary metabolites
into their environment, many of which have profound impacts on agriculture, industry,
environmental sustainability, and human health (Keller et al., 2005). Many compounds
are used as medicines, including statins, penicillin, and other antibiotics. Many others,
like aflatoxins and fumonisins, can be life threatening to humans and animals. Aflatoxin
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B1 (AFB1), a highly carcinogenic secondary metabolite synthesized by a group of
Aspergilli, is a life-threatening toxin causing significant morbidity and mortality
worldwide, as well as billions of dollars in annual economic losses (Magnussen et al.,
2013). Due to the significant human and agricultural impacts of aflatoxin (AF), its
biosynthetic pathway is one of the most characterized and widely studied models for
understanding fungal secondary metabolism (Roze et al., 2011).
The aflatoxin biosynthesis process is activated by several environmental cues and
orchestrated by a complex regulatory network of more than 25 genes and 17 enzymatic
steps (Brakhage et al., 2013; Yin et al., 2011; Yu et al., 2004; Chanda et al., 2009). The
operation of this network is governed by the interactions of a set of global transcription
factors, including LaeA and VeA (Brakhage et al., 2013; Kale et al., 2008; Bayram et al.,
2008; Calvo et al., 2004; Calvo et al., 2008; Duran et al., 2007). Upon receiving signals
from cell surface receptors, these global transcription factors communicate with pathwayspecific transcription factors [examples include AflR (Cary et al., 2006) and GliZ (Scharf
et al., 2012; Bok et al., 2006)] to activate specific aflatoxin biosynthesis genes. Many of
the enzymes synthesized by this pathway then localize to specific vesicles known as
toxisomes (Chanda et al., 2009; Chanda et al., 2010; Roze et al., 2011; Lim et al., 2014;
Menke et al., 2013), which provide a platform for the completion of biosynthesis,
sequestration, and export of aflatoxin to the environment (Chanda et al., 2009; Chanda et
al., 2010; Roze et al., 2011; Lim et al., 2014; Menke et al., 2013).
To manipulate secondary metabolism in fungi for the benefit of public and
environmental health, it is essential to understand the motivation for a fungal cell to
preserve such an energy-consuming metabolic process with enormously complex
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molecular and cellular organization throughout the course of evolution. One of the most
commonly hypothesized functions of fungal secondary metabolites is defense against
other organisms in the same ecological niche. Antibacterial properties of secondary
metabolites like penicillin and other beta-lactam antibiotics are well established in
literature (Van Krimpen et al., 1987). Beyond antibacterial properties, reports from
Rohlfs et al. (Rohlfs et al., 2007) suggest that aflatoxin and sterigmatocystin protect
fungal cells from pests and insects. These studies all suggest that secondary metabolism
provides fungi with a survival mechanism in nature.
Several recent studies suggest that secondary metabolism is integrated with
primary metabolism and its associated cellular mechanisms (Roze et al., 2011; Chanda et
al., 2009; Linz et al., 2012; Roze et al., 2010), which implies that secondary metabolism
may have a regulatory impact on other fungal cellular processes as well. One cellular
process that appears to be associated with secondary metabolism in fungi is oxidative
stress response. Recently, several basic leucine zipper (bZIP) transcription factors in
filamentous fungi have been reported in the literature that not only regulate antioxidant
genes participating in oxidative stress response, but are also associated with the
regulation of secondary metabolism (Roze et al., 2011; Baidya et al., 2014; Hong et al.,
2013; Hong et al., 2013; Montibus et al., 2013; Reverberi et al., 2012; Montibus et al.,
2015; Yin et al., 2013). These reports are in line with previous reports (Jayashree et al.,
2000; Narasaiah et al., 2006; Reverberi et al., 2006; Reverberi et al., 2008) suggesting
that oxidative stress induces aflatoxin synthesis in Aspergillus parasiticus.
While these lines of evidence collectively demonstrate that the two cellular
processes (aflatoxin biosynthesis and intracellular oxidative stress management)
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communicate at different regulatory nodes and are co-regulated, the effect of aflatoxin on
oxidative stress remains unclear. In this study we address this knowledge gap through a
comparative study of total reactive oxygen species (ROS) output between the wild-type
A. parasiticus and its mutant, AFS10, in which the aflatoxin pathway regulator gene,
aflR, is disrupted (Cary et al., 2002; Ehrlich et al., 1999). In addition to measuring ROS,
we also conducted a comparative assessment of superoxide dismutase (SOD) gene
expression. SODs are conserved in eukaryotes and are synthesized in response to
intracellular (O2−) radicals (a type of ROS) generated as a byproduct of primary cellular
functions (Fridovich 1975). To differentiate the aflatoxin-dependent effect on ROS
generation from the possible genetic effects (of aflR disruption) we also conducted
aflatoxin supplementation studies on AFS10. The results of this work provide direct
evidence in support of the regulatory role of aflatoxin synthesis on total ROS output and
explain the rationale for the co-regulation of oxidative stress with aflatoxin synthesis.
4.3 MATERIALS AND METHODS
4.3.1 Strains, media and growth conditions
Aspergillus parasiticus wild type strain SU-1 (ATCC56775) and the aflR
disrupted mutant, AFS10 (Ehrlich et al., 1999; Roze et al., 2007), were used for this
study. Yeast extract sucrose (YES) (2% yeast extract, 6% sucrose; pH 5.8) was used as
the liquid growth medium for the entire study for both strains. Fungal cells were grown
for 24 h and 48 h by inoculating 107 spores per 100 mL of growth medium and
incubating the cells at 29°C in a dark orbital shaker at 150 rpm.
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4.3.2 Quantification of ROS
Comparison of ROS concentrations between SU-1 and AFS10 was conducted
spectrophotometrically using 2′,7′-dichlorofluorescein diacetate (DCFH-DA) based on a
previously described protocol (Chang et al., 2011). Equal weight (0.5 g) of mycelia from
a 24 and 48 h culture was placed into 1 mL of freshly made 1 µM DCFH-DA in
phosphate buffered saline (PBS). After 4 h of incubation in the dark at room temperature
(25°C), the fluorescent yield of the DCFH-DA oxidation product, dichlorofluorescin
(DCF), was measured using a Victor™ X3 2030 Multilabel Reader (PerkinElmer,
Waltham, MA, USA) with an excitation/emission wavelength of 490/525 nm.
4.3.3 Identification of Superoxide Dismutase genes
Since functional characterization of the SOD genes in A. parasiticus has not yet
been completed, a bioinformatics analysis was performed to identify SOD gene
sequences to allow for a comparative expression analyses to address our hypothesis. The
SOD genes analyzed in this study were identified by searching for “superoxide
dismutase” in the accessible genome database (Yu et al., 2008) of A. flavus, a close
relative of A. parasiticus that exhibits ~98–100% amino-acid sequence identity with A.
parasiticus proteins that have been sequenced (Roze et al., 2011). The search rendered
five annotated amino-acid sequences which were then queried in the PROSITE database
(Sigrist et al., 2013) against the 390 available SOD genes to investigate whether they
contained (a) the conserved functional domains typical of SODs, or (b) motifs with a high
probability of occurrence that are commonly present in the SOD genes. Details of these
sequences and queries can be found in table 4.1.
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4.3.4 RNA extraction, purification and cDNA synthesis
Total RNA was extracted from cells harvested using a TRIzol-based (TRIzol
Reagent; Invitrogen, Carlsbad, CA, USA) method previously described (Chanda et al.,
2009). Within 24 h of extraction, RNA cleanup was performed using a Qiagen RNEasy
Cleanup Kit (Qiagen, Valencia, CA, USA), and samples were stored at −80°C. Total
RNA was then reverse transcribed to cDNA using iScript™ cDNA Synthesis Kit
(BioRad Laboratories, Hercules, CA, USA). All samples were checked for concentration
and purity after each step using a NanoDrop 2000 Spectrophotometer (Thermo-Fisher
Scientific, Waltham, MA, USA). All cDNA samples were stored at −20°C until
subsequent PCR quantification.
4.3.5 Quantitative PCR Assays
Expression of SOD genes was examined by quantitative PCR assays (qPCR)
using SsoAdvanced Universal SYBR Green Supermix (BioRad Laboratories, Hercules,
CA) and gene specific forward and reverse primers (table 4.2) designed using Primer3
online software (Ye et al., 2012). Reactions were performed per BioRad SYBR Green
protocol guidelines and quantified using a CFX96 thermal cycler (Bio-Rad Laboratories,
Hercules, CA, USA).
The 18s ribosomal DNA was used as a reference in the gene expression
experiments, with β-tubulin used as a positive control rather than a reference gene. This
use of β-tubulin in this manner provided proof of consistent quantification across all
experiments and revealed an expected range of variation within the protocol. Expression
of each SOD gene was obtained from the threshold cycle values normalized against 18s
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rDNA in each sample. All RT-PCRs were performed in triplicate for each gene per
sample. For quantitative comparison of gene expression, the expression values for each
target gene at the early stationary phase (48 h) were expressed as the fold change relative
to the 24 h time point to reflect changes associated with the initiation of aflatoxin
biosynthesis, which begins at 30 h (Roze et al., 2015). All data analysis was performed
using CFX Manager software (Version 3.1, Bio-Rad Laboratories, Hercules, CA, USA,
2012).
4.3.6 Aflatoxin supplementation experiments
For aflatoxin supplementation studies, 0.5 g of AFS10 mycelia were collected
from YES media at 24 and 48 h and each placed in 12-well trays containing 1 mL of their
culture media. Total aflatoxin (in 70% methanol solution) isolated from an SU-1 culture
using our standard chloroform-methanol isolation procedure (Gummadidala et al., 2017)
was added to each sample well at a final concentration of 50 ppm. The control mycelia
were supplemented with an equal volume of 70% methanol solution. After a 4 h
incubation, mycelia were transferred to 1 mL of 1 µM DCFH-DA in PBS substrate for an
additional 1 hour incubation in the dark before being measured (in triplicate) for DCF
fluorescence. Aflatoxin uptake into the mycelia during the incubation period was
quantified by measuring total percent removal of aflatoxin from the medium every hour
until 4 h and by measuring the total accumulation of aflatoxin in the mycelium in parallel,
after 4 h. Percent removal of aflatoxin from the medium was calculated as follows:
Percent removal = ((Initial total aflatoxin in the supplementation medium − total
aflatoxin in the medium at a time point)/Initial total aflatoxin in the supplementation
medium) × 100. Aflatoxin was quantified in the medium as described below. Aflatoxin
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accumulation in the mycelium was measured after washing three times with PBS buffer
followed by extracting aflatoxin from the mycelium using a chloroform: methanol
procedure as described previously (Roze et al., 2007). Aflatoxin in the extract was then
measured using an enzyme-linked immunosorbent assay (ELISA). Dead cells of AFS10
obtained upon autoclaving at 121°C for 15 min were used in the uptake experiments as
controls for free diffusion systems. Loss of viability in these cells was confirmed prior to
experimentation by confirming their inability to grow in fresh growth medium.
4.3.7 Aflatoxin quantification
Qualitative comparisons of aflatoxin accumulation in the growth media were
performed using thin-layer chromatography (TLC) as described previously (Hong et al.,
2008). Quantification of aflatoxin for the aflatoxin uptake experiments was performed
using a Veratox for Aflatoxin ELISA kit (Neogen Food Safety, Lansing, MI, USA) and
measured on a Stat Fax 4700 Microstrip Reader (Awareness Technologies, Palm City,
FL, USA).
4.3.8 Satistical analysis
Statistical analyses for this study were conducted using the GraphPad Prism
Software (GraphPad, CA, USA). The statistical significance of two-tailed p-values were
determined using an unpaired t-test, using n = 3 and p < 0.05. For the gene expression
studies, a two-fold increase or decrease in transcript level was our cutoff for comparing
expressions between two genes.
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4.4 RESULTS
4.4.1 SU-1 demonstrates a significantly larger decrease in total ROS compared to AFS10
between 24h and 48h
Aflatoxin biosynthesis is activated in SU-1 at 24 h under our culture conditions
and reaches peak levels by the start of the stationary phase at 48 h (Skory et al., 1993;
Chanda et al., 2009). Under these conditions aflatoxin biosynthesis is not activated in
AFS10. As shown in figure 4.1a, during the 24h – 48h time window, aflatoxin
accumulation in the growth medium was observed and aflatoxin genes were activated in
SU-1 but not in AFS10. The genes nor-1 and ver-1 were chosen as representative
aflatoxin genes that demonstrated drastic increases in expression similar to previously
reported semi-quantitative analysis of transcript and protein analysis (Roze et al., 2007).
Quantitative comparison of total ROS (Dichlorodihydrofluorescein [DCF] fluorescence
measurements shown in Figure 4.1b) shows that at 24 h both strains demonstrate similar
levels of total ROS, but by 48 h the total ROS decreased at a significantly higher rate in
SU-1 than in AFS10. This demonstrated an association between the activation of
aflatoxin biosynthesis and a decrease in total ROS, which may be attributable to either
the presence of aflatoxin or the regulatory role of aflR.
4.4.2 Higher total ROS in AFS10 compared to SU-1 at 48h associates with significant
differences in SOD gene expression
4.4.2.1 Bioinformatics analysis of SOD genes
Since SOD genes are synthesized in eukaryotes in response to intracellular O2−
radicals (a type of ROS) generated as a byproduct of primary cellular functions
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(Fridovich 1975), we investigated whether higher ROS at 48 h in AFS10 is correlated
with the transcriptional activation of SOD genes. As a first step to do so we initiated a
search for SOD genes within the available genome database of a closely related species,
A. flavus (Yu et al., 2008) and identified five amino acid sequences (table 4.1). Out of
these five sequences, two different sequences of copper–zinc SOD genes are annotated in
the database as CuZnsod1 and cytosolic CuZnsod, two sequences of iron SOD are
annotated as Fesod and FesodA, and one manganese SOD is annotated as Mnsod. These
five sequences were queried against the PROSITE database (Sigrist et al., 2013) to verify
whether they contained any of the conserved functional domains or patterns that are
present in the well-characterized SODs within the database.
As shown in table 4.2A, two of these sequences contained superoxide dismutase
(SOD) signatures. CuZnsod1 had two typical CuZn SOD signatures. The conserved
sequence (AFHVHQfGDnT) matched with the consensus pattern, [GA]-[IMFAT]-H[LIVF]-H-[S]-x-[GP]-[SDG]-x-[STAGDE], for signature 1, where 2 H’s are copper
ligands. Similarly, conserved sequence (GNAGaRpACgvI) matched with the consensus
pattern, G-[GNHD]-[SGA]-[GR]-x-R-x-[SGAWRV]-C-x(2)-[IV], for signature 2, where
C is involved in a disulfide bond. Mnsod contained the conserved sequence,
DmWEHAYY, corresponding to manganese and iron SOD signature. This signature
matched with the consensus pattern, D-x-[WF]-E-H-[STA]-[FY](2), where D and H are
manganese/iron ligands.
The PROSITE database was then used to investigate whether the three other
sequences that did not contain typical SOD motifs contained regions that have high
probability of occurrence (frequent patterns) in SODs. The remaining three amino acid
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sequences displayed the four patterns (an N-myristoylation site, a Casein kinase II
phosphorylation site, and N-glycosylation site, and a Protein kinase C phosphorylation
site) that are the most frequently present within the 390 SOD genes available in
PROSITE database, suggesting strongly that these are SOD sequences (table 4.2B).
4.4.2.2 Expression profiles of SOD genes
The gene expression of all five SODs was examined in both SU-1 and AFS10 at
24 h and 48 h post-inoculation in yeast extract sucrose (YES). Quantitative comparison of
the transcript levels between 24 h and 48 h, with levels normalized to 24 h (raw
expression data relative to 18s rRNA shown in Figure S1) are shown in figure 4.2 and
the list of primers used are mentioned shown under table 4.3. The data suggest that SOD
expression profile in this fungus is growth phase dependent. Hence, while the expressions
of Fesod and CuZnsod1 are higher in 24 h cultures (corresponding to the exponential
growth phase) the Mnsod expression is significantly higher in the 48 h cultures
(corresponding to the stationary growth phase). As seen in figure 4.2, AFS10 displayed a
significantly larger increase in Mnsod expression from 24 h to 48 h (~70-fold increase in
AFS10 versus a ~40 fold increase in SU-1). Additionally, CuZnsod expression that
remained constant in SU-1 showed a significant increase from 24 to 48 h in AFS10. No
significant difference was observed between SU-1 and AFS10 for genes Fesod and
CuZnsod1. Our results, therefore, demonstrate an association between higher ROS levels
in AFS10 (compared to SU-1) and absence of aflatoxin biosynthesis during the 24 h–48 h
time window in AFS10 with the significantly larger increases (compared to SU-1) in
Mnsod and CuZnsod transcripts from 24 h to 48 h.
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4.4.3 Aflatoxin supplementation to AFS10 growth medium changes total ROS output
without changing the SOD transcript levels
The significantly larger decrease in total ROS in SU-1 compared to AFS10 could
either be aflatoxin dependent, aflR dependent, or both. To examine if total ROS
production is in-part aflatoxin dependent, we investigated whether aflatoxin
supplementation to AFS10 impacts the total ROS levels. The results from this experiment
are shown in figure 4.3. A 4 h supplementation of 24 h mycelia with total aflatoxin
isolated from an SU-1 growth medium resulted in a significant decrease of total ROS
(figure 4.3a). In contrast, the 4 h aflatoxin supplementation to 48 h AFS10 mycelia
significantly increased the total ROS. To understand this differential effect of aflatoxin
supplementation on the 24 h and 48 h AFS10 cultures, we conducted an examination of
aflatoxin uptake by the mycelium during the 4 h time-period. As shown in figure 4.3b,
the percentage removal of aflatoxin per unit mass of mycelium by the end of 4 h was
significantly higher for 48 h cultures than 24 h cultures. This data also agreed with the
aflatoxin accumulation in the mycelia, which demonstrated a significantly higher
accumulation of aflatoxin in 48 h cultures than in 24 h cultures. To examine whether the
aflatoxin accumulation was a free diffusion versus an active uptake mechanism by the
mycelium, we conducted a similar experiment with equal masses of dead AFS10 cultures
obtained upon autoclaving the cultures. Our results demonstrate that while the free
diffusion of aflatoxin from the medium to the immersed dead cells resulted in a faster
removal of aflatoxin from the medium, the aflatoxin could not be retained in the dead
mycelia unlike the live cells, when taken out of the medium and washed. Collectively the
gradual increase in aflatoxin removal from the medium (unlike the dead cells) and the
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ability of retaining the aflatoxin in the mycelium suggests an active uptake mechanism of
aflatoxin by the cells. The significantly higher uptake of aflatoxin in 48 h cultures than
the 24 h cultures suggest that the differential effects of the aflatoxin supplementation on
total ROS in the 24 h versus 48 h cultures are associated with the differential levels of
aflatoxin uptake by the mycelia of these ages.
Finally, we also examined whether aflatoxin supplementation resulted in changes
in the expression levels of the SOD genes either in 24 h or 48 h cultures. Contrary to the
total ROS readings, there were no significant changes in SOD expression that were
attributable to AF supplementation (figure 4.3c), thereby suggesting the possibility that
aflatoxin supplementation induced changes in the total ROS are acute biochemical
effects.
4.5 DISCUSSION
This study provides the first direct demonstration of the regulatory role of a
secondary metabolite on a cellular process of the producer’s oxidative stress
management. It also can now explain the previous reports on the cross-talk between
oxidative stress and secondary metabolism (Jayashree et al., 2000; Narasaiah et al., 2006;
Reverberi et al., 2006; Reverberi et al., 2008). Based on our current findings and
previously published literature, we propose here a ROS management model for aflatoxin
producers (illustrated in figure 4.4). According to this model, aflatoxin biosynthesis
protects cells against ROS accumulation from at least three different sources: (a) primary
metabolic processes, (b) secondary ROS generated from aflatoxin biosynthesis, as
proposed previously by Roze et al. (Roze et al., 2015), and (c) ROS generated upon
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aflatoxin uptake by cells during the stationary phase of growth (aflatoxin
supplementation data from 48 h AFS10 cultures in the current study). The aflatoxindependent protection occurs in one or a combination of the following ways: (a) utilization
of ROS in the biochemical steps of the biosynthesis pathway (Narasaiah et al., 2006), (b)
aflatoxin-dependent reduction of ROS in cells at exponential growth phase (aflatoxin
supplementation data from 24 h AFS10 cultures in the current study) and (c) aflRdependent reduction of ROS (current study) possibly through its gene regulatory impacts
outside the aflatoxin pathway gene cluster (Price et al., 2006; Yin et al., 2012). Our data
support the likelihood that disruption of aflR blocks all the three modes of aflatoxindependent protection, leading to a higher accumulation of super-oxide radicals in AFS10
compared to SU-1. This can explain the increased demand for SOD activation and the
higher SOD transcript levels in AFS10 than in SU-1.
To address the direct effect of aflatoxin on total ROS, we designed a 4 h
supplementation experiment to compare the individual effects of the supplementation on
the 24 h and the 48 h AFS10 cultures. We understand based on previous literature (Roze
et al., 2007; Banerjee et al., 2014; Chanda et al., 2009) that 24 h cultures and 48 h
cultures (under our standard growth conditions), are very different physiological systems;
24 h cultures demonstrate no secondary metabolite synthesis and in 48 h cultures
secondary metabolite synthesis occurs at peak levels. The 4 h time was optimized from
initial uptake experiments in which we noticed no significant increase in the growth of
the mycelia until 4 h under the given experimental conditions (data not shown). We
reasoned that supplementation beyond 4 h would result in adaptation of fungal cells and
that would not allow us to observe the acute effects as described in this study.
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It is speculated that fungal toxisomes, which are sites for the synthesis and
compartmentalization of secondary metabolites (Chanda et al., 2009; Roze et al., 2011),
receive input from peroxisomes and mitochondria as well as from the secretory and Cvt
vesicle transport pathways (Roze et al., 2011). A significant increase in the mitochondrial
SOD, MnSOD, at 48 h suggests that it is primarily responsible for dismutating the
superoxides during the stationary phase. Previous proteomic data on fungal toxisomes in
A. parasiticus (Linz et al., 2012) demonstrated an enrichment of superoxide dismutases,
especially MnSOD, within the toxisomes as well. Catalases also present in the tosixomes
then convert the hydrogen peroxide product of the dismutation reactions into oxygen and
water. The data shown here correspond increased MnSOD with ROS levels after the
initiation of aflatoxin biosynthesis support the possibility that superoxides are
compartmentalized into fungal toxisomes in addition to the mitochondria, and become
available for incorporation into secondary metabolite biosynthetic pathways, including
aflatoxin synthesis, in addition to dismutation by SODs. We emphasize here that while
the SOD expression profiles are closely and independently associated with total ROS and
the activation of aflatoxin biosynthesis, our data (figure 4.3c) do not support aflatoxin as
a direct regulator of SOD gene transcription, thereby suggesting that additional
regulator(s) work in concert with AflR to regulate SOD gene expression. An example of
such a regulator is the bZIP transcription factor AtfB (Roze et al., 2011; Wee et al.,
2017), which is in part one regulator of the SODs and the cellular response to
intracellular oxidative stress (Hong et al., 2013; Hong et al., 2013; Wee et al., 2017) that
binds to aflR gene promoter and physically interacts with the AflR (Miller et al., 2005;
Roze et al., 2004).
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One limitation of this study is the lack of an appropriate methodology for clean
biochemical measurements specific for superoxide radicals (O2−) within Aspergillus cells.
Commercially available small molecules like DMPO, that can successfully trap O2−
within mammalian and yeast cells, have conventionally been used for such O2quantifications. However, these small molecules fail to enter Aspergillus cells (data not
shown). Within the cell, toxisomes are very dynamic systems that are continuously
exporting protein and metabolite contents to the extracellular environment (Chanda et al.,
2010), at which time any present superoxide radicals would be detectable by molecules
such as DMPO. Therefore, unless the extremely unstable O2− radicals are incorporated
into the location of aflatoxin synthesis within toxisomes, as in case of SU-1 (but not in
AFS10), commercial cellular stains like MitoSOX or CellROX cannot provide a true
overall quantification of the total O2− radicals or total ROS through cellular imaging
experiments as done for many mammalian cells, and will lead to inaccurate
interpretations. The protocol used in these experiments is based on a methodology
previously established by Chang et al. (Chang et al., 2011). The method allows the
substrate DCFH-DA to react with the total ROS generated within mycelia and form the
fluorescent marker DCF that can then be quantified spectrophotometrically. While we
acknowledge the technical limitations of the DCFH-DA probe in providing an accurate
quantification of superoxides and total ROS (Kalyanaraman et al., 2012), we reason that
our experimental design, being dependent of relative ROS levels rather than accurate
ROS quantifications, was able to circumvent these challenges and therefore our
interpretations on relative ROS levels were not impacted.
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In conclusion, our findings establish the foundation for a long-term study that will
investigate the molecular, cellular, and biochemical mechanisms underlying the
differential effects of aflatoxin on ROS accumulation in cells that are in an exponential
growth phase versus those in a stationary phase. We hypothesize based on these findings
that secondary metabolites have a regulatory role in the cellular coordination of
secondary metabolism and oxidative stress response in filamentous fungi. Our future
studies will shed more light on revealing the complexity of such coordination and thereby
help identify novel targets for the manipulation of secondary metabolism.
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Table 4.1: Amino acid sequences of the SODs analyzed in the study. The names of the
SODs as annotated in the gene bank database and their accession numbers are mentioned
above each sequence within the shaded rows.
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Table 4.2: A bioinformatics analysis of the SOD annotated amino acid sequences. (A)
Results from a search of the conserved domain signatures of SODs. Two sequences,
CuZnSOD1 and MnSOD (shaded cells) show the typical SOD signatures. (B) (i) Results
from a study of the detection of the most frequent patterns of the SODs available in the
PROSITE database. A total of 390 SOD sequences were analyzed. The cells with the four
most frequent patterns are highlighted in the table. (ii) Results from the analysis of the
four most frequent patterns within the sequences (CuZnSOD cytosolic, FeSOD,
FeSODA) that did not show conserved domain signatures.
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Table 4.3: List of primers used in the study.
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Figure 4.1: Decrease of total ROS during activation of aflatoxin biosynthesis. (a)
Comparison of Figure 1. Decrease of total ROS during activation of aflatoxin
biosynthesis. (a) Comparison of (i) aflatoxin accumulation and (ii) Gene expression
levels relative to 24 h of three aflatoxin pathway aflatoxin accumulation and (ii) Gene
expression levels relative to 24 h of three aflatoxin pathway genes in SU-1 and AFS10.
(b) Comparison of total ROS at 24 h and 48 h. The error-bars represent genes in SU-1
and AFS10. (b) Comparison of total ROS at 24 h and 48 h. The error-bars represent
standard error of the mean. The two-tailed p-value was determined using unpaired t-test
(GraphPad standard error of the mean. The two-tailed p-value was determined using
unpaired t-test (GraphPad statistical software). #, Significant difference of transcript
levels between 24 h and 48 h (p-value < 0.05, statistical software). #, Significant
difference of transcript levels between 24 h and 48 h (p-value < 0.05, n = 3); * Significant
difference of total ROS between SU-1 and AFS10 (p-value < 0.05, n = 3).

55

Figure 4.2: Comparison of SOD gene expression in SU-1 and AFS10. Quantitative PCR
(qPCR) comparison of SOD gene expression in the two strains at 24 and 48 h of culture
growth. All expression quantification were conducted in triplicate. For each gene the
expression value was normalized against the 18s rRNA reference gene and compared to a
beta-tubulin control. The expression values for each target gene at early stationary phase
(48 h) were expressed as the fold change relative to 24 h time point. Fold changes ≥2.0
were considered up- or down- regulated. All data and statistical analysis (Student’s t-test)
were performed using CFX Manager software (Bio-Rad Laboratories). Compared to 24 h
gene expression, FeSOD showed a significant decrease in both the wild-type (2.1-fold; p
= 0.003) and AFS10 (3.9-fold; p < 0.001); FesodA showed no significant change for
either strain; CuZnsod expression did not change in the WT, but showed a 2.1-fold
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increase (p = 0.003) in AFS10; CuZnsod1 showed a large, significant decrease in
expression for both the WT (22.4-fold; p = 0.001) and AFS10 (26.4-fold; p < 0.001);
Mnsod had a dramatically significant 36.2-fold increase in gene expression in the WT (p
< 0.001), and an even greater 69.8-fold increase in AFS10 (p < 0.001) compared 24 h
expression. (Raw gene expression data is included as Figure 4.5). * Indicates statistically
significant difference from respective 24 h gene expression; p ≤ 0.05.
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Figure 4.3: Aflatoxin supplementation to AFS10. (a) Effect on total ROS. A quantitative
comparison of ROS in AFS10 supplemented with 50 ppm aflflatoxin (in 70% methanol)
and a 70% methanol control was conducted. Total ROS was quantiffiied at 24 h and 48 h
of growth + 4 h of incubation in 1 µµM 20,70-dichlorofluorescein diacetate (DCFH-DA)
in phosphate buffered saline (PBS) substrate with 2′,7′-dichlorofluorescein diacetate
(DCFH-DA) in phosphate buffered saline (PBS) substrate with the the corresponding AF
concentration. Error-bars represent SEM. (*) denotes statistically significant
corresponding AF concentration. Error-bars represent SEM. (*) denotes statistically
significant difference (p < 0.05; n = 3) in ROS compared to the 70% methanol control for
the corresponding growth difference (p < 0.05; n = 3) in ROS compared to the 70%
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methanol control for the corresponding time. (b) Cellular uptake of aflatoxin during
aflatoxin supplementation. (i) Percent removal of aflatoxin growth time. (b) Cellular
uptake of aflatoxin during aflatoxin supplementation. (i) Percent removal from the
supplementation medium in live cells of 24 h and 48 h AFS10. The percent removal was
of aflatoxin from the supplementation medium in live cells of 24 h and 48 h AFS10. The
percent calculated at every hour until 4 h to compare the aflatoxin removal pattern by live
cells with the dead removal was calculated at every hour until 4 h to compare the
aflatoxin removal pattern by live cells cells that allow free diffusion from the medium
into the cells. (ii) Percent aflatoxin accumulation in with the dead cells that allow free
diffusion from the medium into the cells. (ii) Percent aflatoxin the mycelium of 24 h and
48 h cultures. Aflatoxin in the mycelia of live cells was compared to the accumulation in
the mycelium of 24 h and 48 h cultures. Aflatoxin in the mycelia of live cells was dead
cells. Error-bars represent SEM. a, statistically significant difference (p < 0.05; n = 3) in
aflatoxin compared to the dead cells. Error-bars represent SEM. a, statistically significant
difference (p < 0.05; n levels with 0 h, b, statistically significant difference (p < 0.05; n =
3) in aflatoxin levels between 24 h = 3) in aflatoxin levels with 0 h, b, statistically
significant difference (p < 0.05; n = 3) in aflatoxin levels and 48 h cultures, c, statistically
significant difference (p < 0.05; n = 3) in aflatoxin levels between between 24 h and 48 h
cultures, c, statistically significant difference (p < 0.05; n = 3) in aflatoxin levels live and
dead cells at a particular time-point. (c) Comparison of SOD gene expression in aflatoxin
between live and dead cells at a particular time-point. (c) Comparison of SOD gene
expression in supplemented and control AFS10. qPCR comparison of SOD gene
expression in the control and 4 h aflatoxin supplemented and control AFS10. qPCR
comparison of SOD gene expression in the control aflatoxin supplemented cells. The
gene expression values were normalized against the 18s rRNA and 4 h aflatoxin
supplemented cells. The gene expression values were normalized against the 18s
reference gene. Fold changes 2.0 were considered up- or down-regulated. All data and
statistical analysis (Student’s t-test) were performed using CFX Manager software (BioRad Laboratories).
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Figure 4.4: Proposed model for total ROS management in A. parasiticus. Based on our
current findings and previous reports we propose that aflatoxin-dependent protection
occurs in one or a combination and previous reports we propose that aflatoxin-dependent
protection occurs in one or a combination of the following ways: (a) utilization of ROS in
the biochemical steps of the biosynthesis pathway (Narasaiah et al., 2006), (b) aflatoxindependent reduction of ROS in cells at exponential growth phase (current study) of the
following ways: (a) utilization of ROS in the biochemical steps of the biosynthesis
pathway (b) aflatoxin-dependent reduction of ROS in cells at exponential growth phase
(current study) and (c) aflR- dependent reduction of ROS (current study) possibly
through its gene regulatory impacts outside the aflatoxin pathway gene cluster (Price et
al., 2006; Yin et al., 2012). Aflatoxin dependent biochemical processes that sequester
ROS still remain uncharacterized (green dashed arrow). Pink arrows indicate the sources
of ROS accumulation. These include ROS generation from primary metabolic processes,
secondary ROS generated from aflatoxin biosynthesis (Roze et al., 2015), and ROS
generated upon aflatoxin uptake by cells during stationary phase of growth (based on
aflatoxin supplementation data from 48 h AFS10 cultures in the current study). The
mechanisms that result in ROS accumulation upon cellular uptake of aflatoxin remains
uncharacterized (pink dashed arrow). The model can now explain the physiological need
of the cells to co-regulate secondary metabolism (in this case, aflatoxin biosynthesis) and
oxidative stress response through the bZIP proteins (Roze et al., 2011; Baidya et al.,
2014; Hong et al., 2013; Hong et al., 2013; Montibus et al., 2013; Reverberi et al., 2012;
Montibus et al., 2015; Yin et al., 2013). Red arrows indicate the contributions of the
current study. The molecular mechanism aflR-mediated regulation of SOD genes remains
uncharacterized (red dashed arrow) and will be investigated in our follow up studies.
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Figure 4.5: Raw expression data of the SOD genes in SU-1 and AFS10. qPCR
comparison of SOD gene expression in the two strains at 24 h and 48 h of culture growth.
All expression quantifications were conducted in triplicate. For each gene the expression
value was normalized against and 18s rRNA reference gene and compared to a β-tubulin
control
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CHAPTER 5
Vibrio gazogenes: A NOVEL TOOL TO COMBAT THE PATHOGEN,
Aspergillus flavus1

1

Gummadidala PM., Omebeyinje M., Deo T., Chanda A. To be submitted to Science.
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5.1 ABSTRACT
Aspergillus flavus is the most virulent and second most important Aspergillus
species causing human infections ranging from hypersensitivity reactions to invasive
infections (Hedayati et al., 2007). The Aspergillosis caused by A. flavus has a 90%
mortality rate primarily due to the development of multi drug resistance. A. flavus also
produces aflatoxins that contaminate food supplies globally and which when consumed
lead to hepatocellular carcinoma. Biological controls were proven to be most effective in
inhibiting aflatoxins and aflatoxin producing fungi. Vibrio gazogenes was proven to
synthesize antifungal and antiaflatoxin metabolites. In this study we treated A. flavus
cultures with 16 million V. gazogenes cells and observed >99% significant decrease in
aflatoxin levels in the first generation and ~40% decrease of aflatoxin levels in the second
generation of A. flavus cultures. The dead and live V. gazogenes cells have similar
aflatoxin inhibitory effects that were specific to V. gazogenes and not to other grampositive or gram-negative bacterium. Infecting corn kernels with A. flavus in the presence
of bacterium significantly decreased the fungal conidial growth by 80% and aflatoxin by
>98%. Treating drosophila flies with V. gazogenes prior to A. flavus infection increased
their survival (~40%). Using confocal laser, scanning electron and transmission electron
microscopies we observed the uptake of the bacterium by the fungus into endosome like
compartments. RT-PCR data revealed controversial gene expressions of aflatoxin
pathway genes and global secondary metabolite regulatory genes in the presence of live
and dead V. gazogenes. These data suggest that the live and dead V. gazogenes aflatoxin
inhibitory mechanisms are different. The data also uncover the yet unstudied concept that
V. gazogenes mechanism of aflatoxin inhibition is not at the gene level but is at the
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cellular level. Finally our study has discovered a novel tool (Vibrio gazogenes) to inhibit
the aflatoxin production and pathogenicity of plant and human pathogen Aspergillus
flavus.
5.2 INTRODUCTION
The fungus Aspergillus flavus is a saprophyte, growing in humid environments
with pathogenic ability causing aspergillosis in immuno-compromised humans effecting
the skin, oral mucosa and subcutaneous tissues (Hedayati et al., 2007). Furthermore, A.
flavus is the most virulent and second most important Aspergillus species causing human
infections ranging from hypersensitivity reactions to invasive infections (Hedayati et al.,
2007). According to the centers for disease control and prevention (CDC) approximately
4.8 million cases of aspergillosis were diagnosed worldwide and A. flavus is the second
most leading cause. Most A. flavus strains are susceptible to antifungal therapy but the
minimum inhibitory concentrations are atleast two fold higher than for other Aspergillus
species (Krishnan et al., 2009). Furthermore, recent discoveries revealed the presence of
active multi drug resistant genes in A. flavus strains increasing their potential for drug
resistance and increased pathogenicity (Tobin et al., 1997) (Van Der Linden et al., 2011).
A. flavus is also a plant pathogen and releases aflatoxins that are secondary
metabolites and aflatoxin B1 had been categorized as class 1A human carcinogen by the
International Agency of Research on Cancer (IARC). Aflatoxins contaminate a wide
range of crops, produce, food, nuts, cereal, milk, juices, homes, wood, etc., and can be
ingested into intestines and enter systemic circulation causing aflatoxicosis and liver
cancer. Aflatoxin B1 synthesized by A. flavus is extremely stable (Garcia et al., 1994) at
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temperatures greater than 150OC maintained for 30 minutes (Raters and Matissek 2008)
and so cannot be detoxified by cooking or autoclaving. Therefore aflatoxins pollute many
food groups that are ingested by humans and animals. Most common methods used in
agriculture to reduce aflatoxin contamination are expensive, time consuming and have
low efficiency with limited success rates. Novel therapies are required to fight against A.
flavus strains and inhibit both its pathogenicity and aflatoxin production without affecting
the host physiology. In their zeal to find new anti-fungal and anti-aflatoxin agents
scientists have turned towards plant and microbe derived compounds especially from
organisms that live in aflatoxin induced environments (Holmes et al., 2008).
Vibrio gazogenes is a marine gram-negative bacterium notoriously known for its
synthesis of antifungal pigments (Darshan and Manonmani 2015). Studies have shown
that when V. gazogenes comes in contact with aflatoxin, the toxin induces V. gazogenes
to synthesize antifungal and anti-aflatoxin metabolites termed aflatoxin responsive
metabolites (ARMs). ARMs are responsible for decreasing 60% of aflatoxin by inhibiting
the aflatoxin biosynthetic pathway at the gene level (Gummadidala et al., 2016). But
various studies have shown that when the bacterium and fungus (A. flavus or A.
parasiticus) have been co-cultured then the aflatoxin production was inhibited by greater
than 95% (Chang and Kim 2007, Wang et al., 2013). Also Lactobacillus pentosus and
Lactobacillus beveris bacteria have been successfully used to eliminate aflatoxin B1 from
contamination of milk via the binding of aflatoxin B1 to the bacteria (Hamidi et al.,
2013).
These studies have prompted us to hypothesize that co-culturing V. gazogenes
bacterium with A. flavus fungus will have significant inhibitory effects on the aflatoxin
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biosynthesis of A. flavus. In this study, we treated A. flavus with live and dead V.
gazogenes cells and observed the decrease in aflatoxin with no effect on fungal mycelial
growth. We further conducted microscopic imaging and observed the uptake of V.
gazogenes into endosome like compartments in A. flavus. To understand the mechanism
of action of V. gazogenes we performed transcript accumulation analysis and surprisingly
concluded that V. gazogenes aflatoxin inhibitory activity is not at the gene level but
possibly at the cellular level. Finally our tests to understand the effect of V. gazogenes on
pathogenicity of A. flavus reveal the decrease of aflatoxin and conidial formation in corn
and increase of survival in drosophila that were infected with A. flavus. Definitively we
report the discovery of a novel tool (V. gazogenes) to combat the aflatoxigenicity and
pathogenicity of A. flavus.
5.3 METHODS AND MATERIALS
5.3.1 Strains, media and growth conditions
The fungus Aspergillus flavus strain CA14PyrG.1 (acquired from USDA) and
bacteria Vibrio gazogenes (ATCC29988), Staphylococcus aureus (ATCC), and
Escherichia coli (ATCC) were used for this study. Yeast extract sucrose (YES) (2%
yeast extract, 6% sucrose; pH 5.8) was used as the liquid growth medium and potato
dextrose agar (PDA) and YES agar (YESA) were used as the solid growth media, for A.
flavus. Fungal cells were grown for 72 h (as required by experiments) by inoculating
0.5x106 spores per 50 mL of liquid growth medium and incubated at 29°C in a dark
orbital shaker at 150 rpm. For growth of fungal mycelia on solid media, 2x104 spores
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were center inoculated on 100 mm petri dishes containing 10 mL of PDA/YESA and
incubated in the dark at 29°C.
Difco Marine broth (cat # 2216, BD Biosciences, Sparks, MD) was used, as liquid
growth media for V. gazogenes and the bacterial cells were grown for 24 h by inoculating
105 colony forming units (cfu) /100 ml of growth medium. The cultures were incubated at
29°C in a dark orbital shaker at 150 rpm. Tryptic soy broth (TSB, cat # 211822, BD
Biosciences, Sparks, MD) was used as liquid growth media for S. aureus, and E. coli.
Small inoculum were grown with 105 cfu/5 ml liquid growth media and incubated
overnight at 37°C in a dark orbital shaker at 150 rpm. At the end of the incubation time,
100,000 cells were taken from the small inoculum and further used to inoculate 100 ml
TSB and incubated for 24 h at 37°C in a dark orbital shaker at 150 rpm.
5.3.2 A. flavus treatment with V. gazogenes, S. aureus, and E. coli
The fungus A. flavus was treated with both live (V. gazogenes) and dead bacteria
(V. gazogenes, S. aureus, and E. coli). The 24 h bacterial cultures were spun down at
4000 rpm for 15 min at room temperature and resuspended using YES media. With the
help of absorbance measurements at 600 nm, 4, and 16 million cells from a 24 h bacterial
culture (live or made unviable by boiling at 100OC for 10 min in a hot plate) were sorted
out and added to the 50 ml YES liquid media simultaneous with 5x105 A. flavus spores
and incubated at 29°C in a dark orbital shaker at 150 rpm for 24 h, 48 h and 72 h. At the
end of incubation, A. flavus mycelia were harvested by filtering the mycelia through a
miracloth (Millipore, Billerica, MA) and the cells subjected to appropriate processing for
various growth measurements, aflatoxin analysis and gene expression analysis.
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Comparably 4 or 16 million V. gazogenes cells (viable or unviable) were spread
out as a monolayer on the YESA or PDA 10 cm media plates. The bacterial cells were
allowed to dry in the biosafety cabinet and 2x104 spores of A. flavus were center
inoculated. The hyphal growth of the fungus was recorded daily and at the end of the
incubation period the YES and PDA media was chopped up and used appropriately for
further processing of aflatoxin analysis.
5.3.3 Growth measurements of A. flavus, V. gazogenes, S. aureus, and E. coli
All fungal growth in liquid media was quantified by using dry weight
measurements. Briefly, the mycelia were filtered out of the growth media using a
miracloth (Millipore, Billerica, MA) and dried in an oven at 80°C for 6 h and the weight
difference before and after drying was recorded. To estimate growth of A. flavus on PDA
and YESA media plates, the spread of mycelial colony was measured daily. After 9 days
of incubation time, spores were manually collected from PDA plates using 1xPBS with
0.01% tween and resuspended in 50% glycerol. Spores were counted using
haemocytometer. All bacterial growth measurements were performed using absorbance
readings of growth media at 600 nm. An absorbance of 1.2 on the UV/Vis
spectrophotometer was considered as 106 cells/ml bacterial cellular density and
calculations were performed for 4 and 16 million bacterial cells appropriately.
5.3.4 Aflatoxin measurements
5.3.4.1 Aflatoxin ELISA analysis
Aflatoxin was extracted from A. flavus cultured YES liquid media by adding
equal volume of chloroform in a separating funnel and collecting the organic layer.
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Chloroform was evaporated from the organic layer and the residual aflatoxin was
resuspended in 1 ml of 70% methanol. Aflatoxin was extracted from A. flavus cultures
grown in/on YES and PDA media plates by chopping the agar media and vigorously
shaking it with equal volume of chloroform. Again the chloroform layer was collected,
evaporated and the residual aflatoxin was resuspended in 1 ml of 70% methanol. The
resuspended aflatoxin extract was spun down at 15,000 rpm for 1 min at room
temperature to remove extra debris from the media and mycelia. The clear aflatoxin
extract was used for analyzing aflatoxin using the Neogen Veratox Aflatoxin ELISA kit
(cat # 8030) from Neogen (Lansing, MI, USA) and measured on a Stat Fax 4700
Microstrip Reader (Awareness Technologies, Palm City, FL, USA) as per kit’s protocols.
The ELISA has 2 ppb and 50 ppb as lower and upper limits of detection respectively.
Therefore highly concentrated aflatoxin samples were diluted to fit within the detection
range.
5.3.4.2 Metabolite analysis using UPLC system
The Food and Feed Safety Research Unit at USDA performed metabolite analysis
using UPLC (Ultra high pressure liquid chromatography). Cultures of A. flavus
(with/without V. gazogenes) (50 ml) were lyophilized and then extracted twice with 5%
methanol / 95% ethyl acetate + 0.1% formic acid (15 ml) overnight with shaking at room
temperature. The 2 extractions were pooled and concentrated in vacuo. The dried extract
was redissolved in methanol at 5 mg/ml and centrifuged (14,000 rpm, 2 min) to remove
particulate prior to analysis. Samples were analyzed using a Waters Acquity UPLC
system (40% methanol in water, BEH C18 1.7 µm, 2.1 x 50 mm column) using
fluorescence detection (Ex= 365 nm, Em= 440 nm). Samples were diluted 10-fold if the
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aflatoxin signal saturated the detector. Analytical standards (Sigma-Aldrich, St. Louis,
MO) were used to identify and quantify aflatoxin B1 (AFB1, retention time = 4.60 min.).
Aflatoxin concentrations are expressed in ng aflatoxin / ml culture or ng aflatoxin / g
mycelium.
Simultaneously samples were also analyzed for Cyclopiazonic acid, on a Waters
Acquity UPLC system using PDA UV and Qda mass detection with the following
gradient solvent system (0.5 ml/min, solvent A: 0.1% formic acid in water; solvent B:
0.1% formic acid in acetonitrile): 5% B (0-1.25 min.), gradient to 25% B (1.25-1.5 min.),
gradient to 100% B (1.5-5.0 min.), 100% B (5.0-7.5 min.), then column equilibration 5%
B (7.6-10.1 min.). Cyclopiazonic acid was identified using an authentic standard
purchased from Sigma Aldrich (CPA, retention time = 4.10 min, M+H = 337.2 m/z). CPA
concentrations are expressed in ng CPA / ml culture or ng CPA / g mycelium.
5.3.5 RNA extraction, purification and cDNA synthesis
Total RNA was extracted from fungal cells harvested using a TRIzol-based (TRI
Reagent®; cat # T9424, Sigma, Carlsbad, CA, USA) method. The harvested mycelia
were ground with a mortar and pestle in liquid nitrogen. The cold powdered mycelia was
mixed with TRI Reagent® and chloroform and the mix was spun down at 10,000 rpm for
10 min at room temperature. The organic layer was mixed with equal volumes of
isopropanol and incubated on ice for 15 min and later centrifuged at 10,000 rpm for 15
min at room temperature. The precipitated crude RNA was washed with 70% ethanol and
resuspended in RNAse/DNAse free water (Sigma, Carlsbad, CA, USA). Within 24 h of
extraction, RNA cleanup was performed using a Qiagen RNEasy Cleanup Kit (Qiagen,
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Valencia, CA, USA), as per kit’s instructions and samples were stored at −80°C. Total
RNA was then reverse transcribed to cDNA using iScript™ cDNA Synthesis Kit
(BioRad Laboratories, Hercules, CA, USA) as per kit’s instructions. All samples were
checked for concentration and purity after each step using a NanoDrop 2000
Spectrophotometer (Thermo-Fisher Scientific, Waltham, MA, USA). All cDNA samples
were stored at −20°C until subsequent RTPCR quantification.
5.3.6 Quantitative PCR Assays
Expression of global secondary metabolism genes (laeA, veA, AtfB), aflatoxin
pathway genes (aflR, nor-1, ver-1), pathogenic genes (SAP) and superoxide dismutase
(SOD) genes (MnSOD, CuZnSOD) was examined by quantitative PCR assays (qPCR)
using SsoAdvanced Universal SYBR Green Supermix (BioRad Laboratories, Hercules,
CA). Gene specific forward and reverse primers were designed using Primer3 online
software (Ye et al., 2012). Reactions were performed as per BioRad SYBR Green
protocol guidelines and quantified using a CFX96 thermal cycler (Bio-Rad Laboratories,
Hercules, CA, USA). All RT-PCRs were performed in triplicate for each gene per
sample. The 18s ribosomal DNA was used as a reference gene in the gene analysis. The
gene expression values of A. flavus obtained from the threshold cycle values were
normalized to the 18s rDNA of each sample. We choose 24, 30 and 40 h to study the
transcripts of the genes (explained later in results). For quantitative comparison of gene
expressions, the values for each target gene at 30 h and 40 h were expressed as fold
change relative to the 24 h time point of that specific treatment condition. Data analysis
was performed using CFX Manager software (Version 3.1, Bio-Rad Laboratories,
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Hercules, CA, USA, 2012). Significant change in gene expression was considered if fold
change was ≥ 2 and p-value was < 0.01.
5.3.7 Imaging of fungus and bacteria
5.3.7.1 Confocal microscopy
A. flavus was grown on a cover slip and treated with V. gazogenes for 6 h. The
fungal mycelia were fixed using 4% formaldehyde and washed using 1xPBS and 0.05%
tritionX-100. The resulting mycelia were studied and imaged using Leica TCS SP5
confocal microscope at 20x magnification.
5.3.7.2 Scanning electron microscopy
A. flavus was treated with 16 million live V. gazogenes cells for 48 h in YES
liquid medium and the mycelia were harvested and fixed using 3% glutaraldehyde and
2% osmium tetroxide, dehydrated in ethyl alcohol, and dried using LADD critical point
dryer. Samples were later coated with gold using Denton Vacuum Desk II sputter coater.
The coated samples were loaded onto TESCAN Vega-3 SBU scanning electron
microscope and studied at 17k magnification to understand the effect of V. gazogenes by
A. flavus hyphae.
5.3.7.3 Transmission electron microscopy
Briefly A. flavus was treated with 16 million live V. gazogenes cells for 48 h in
YES medium. Mycelia were harvested, fixed using 3% glutaraldehyde and 2% osmium
tetroxide, dehydrated in ethyl alcohol, and made into blocks using resin mix. The resin
blocks were trimmed and cross-sectioned into 80 nm thick sections using a diamond
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knife (Micro Star Technology Inc., Huntsville, Texas) loaded onto a Sorvall Porter-Blum
MT2-B Ultra-Microtome. The sections were loaded onto copper grids, and later stained
with lead stain and 5% uranyl acetate. The stained grids were then loaded onto Hibachi
H8000 scanning transmission electron microscope. Pressure was maintained at 10-7 Torr,
accelerating voltage at 200kV and images were taken at low magnification (10,000x) and
at high magnification (20,000x) and the localization of the bacterium in A. flavus cells
was studied.
5.3.8 Corn treatments
Corn kernels were infected with A. flavus in the presence and absence of live V.
gazogenes. Briefly fresh commercial packaged corn was bought from grocery store and
kernels were separated. The kernels were then poked with a toothpick or needle to make a
microscopic hole to mimic an insect bite. 10 kernels were placed in each set and 3 sets
were in each treatment condition – corn with no infection (negative control), corn with V.
gazogenes (positive control for bacteria), corn with only A. flavus (positive control for
fungal infection), and corn with A. flavus and live V. gazogenes (the treatment set). A
monolayer of 400,000 live V. gazogenes cell suspended in YES media was applied to the
kernels and semi dried. 10,000 A. flavus spores were inoculated on top of the bacterial
layer for the treatment conditions. Microscopic images using a Leica dissection
microscope were taken to observe and record the effect of V. gazogenes on A. flavus
infection. The percentage of infection was estimated (after 48 h of incubation) by
comparing the number of infected kernels in the presence and absence of V. gazogenes.
After 5 days of incubation the kernels were ground in chloroform and filtered. The filtrate
was evaporated and residual extract was rinsed out with 100% methanol. Methanol was
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evaporated and extracted aflatoxin was resuspended in 1 ml of 70% methanol. The
resuspended aflatoxin extract was spun down at 15,000 rpm for 1 min at room
temperature to remove extra debris from the corn and mycelia. The clear aflatoxin extract
was used for analyzing aflatoxin using the Neogen Veratox Aflatoxin ELISA kit (cat #
8030) from Neogen (Lansing, MI, USA) and measured on a Stat Fax 4700 Microstrip
Reader (Awareness Technologies, Palm City, FL, USA) as per kit’s protocols. The
ELISA has 2 ppb and 50 ppb as lower and upper limits of detection respectively. Thus
highly concentrated aflatoxin samples were diluted to fit within the detection range.
5.3.9 Drosophila fly treatment
Drosophila melanogaster female flies of 3-5 days old were treated with A. flavus
in the presence and absence of live V. gazogenes and the survival of the flies were
recorded. Method used was published by Ramírez-Camejo et al., in 2014. Drosophila
flies were anaesthetized using carbon dioxide and placed on a PDA 10 cm agar plate
containing A. flavus colony with spores. The flies were rolled on the plates by agitation
for 1 min to make them inoculated and then transferred to tubes containing food. (To
quantify the number of spores, the inoculated flies were vortexed in sterile water
containing 0.01% Tween 80 and centrifuged to spin down the spores, which were then
counted using haemocytometer – 2 to 4 x104 spores attached/fly). The flies were
transferred to fresh media tube after 1 h to loose any extra spores. For control or
untreated fly treatments 25 flies per tube of 3 tubes were used. For V. gazogenes
treatments 29 flies per tube of 3 tubes were used. For V. gazogenes treatments the
drosophila flies were starved for 8 h and then given feed containing V. gazogenes for next
24 h. The flies were anaesthetized using carbon dioxide and rolled on PDA 10 cm plates
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grown with A. flavus similar to the control flies. These infected flies were placed back on
V. gazogenes containing feed and the feed was replaced with fresh feed containing V.
gazogenes every 24 h. At the end of 7 days the survival of the flies as compared to
controls (negative control had no A. flavus infection and positive control had A. flavus
infection but no V. gazogenes) was observed and recorded.
5.3.10 Statistical analysis
All experiments were performed in triplicate. Microsoft Excel was used to
generate graphs, perform statistical analysis and calculate significance for dry weight
measurements and aflatoxin analysis. Significance was considered when p value was less
than 0.01. RT-PCR statistical analysis was performed using CFX manager software with
parameters set for significance at p-value <0.01 and gene expression fold change ≥ 2.
5.4 RESULTS
5.4.1 V. gazogenes inhibits aflatoxin production of A. flavus without effecting growth of
the fungus
To understand the effect of V. gazogenes on A. flavus growth and aflatoxin
synthesis, we initially performed a dose response of multiple cellular concentrations of V.
gazogenes on A. flavus. The fungus was treated with 4 and 16 million V. gazogenes cells
in YES liquid media for 48 h. The dry weight analysis at the end of the incubation period
revealed that the mycelial growth of A. flavus did not differ with either 4 or 16 million V.
gazogenes cells as compared to the untreated control (Figure 5.1a). On the other hand, the
aflatoxin levels analyzed using ELISA technique show that there were nearly
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undetectable levels of aflatoxin in the YES liquid media in the presence of V. gazogenes
(irrespective of cellular concentration) as compared to the untreated control (Figure 5.1b).
Most surfaces in the environment on which A. flavus thrives are solid. Thus we
performed similar experiments on YESA solid media. A. flavus was treated with different
bacterial cellular concentrations of 4 and 16 million V. gazogenes cells on the YESA
media plates and the spread of the fungal colony on the media was measured and
recorded daily. The graph in figure 5.1c reveals that V. gazogenes decreases the A. flavus
growth by 25% regardless of the bacterial cellular concentration. Aflatoxin analysis at the
end of 9 days of incubation showed that 16 million V. gazogenes cells significantly
decreased aflatoxin production to nearly undetectable levels where as 4 million V.
gazogenes cells only made a 25% difference as compared to the untreated control (figure
5.1d).
These data clearly state that 16 million V. gazogenes cells consistently and
significantly decrease aflatoxin production (>99%) in both solid and liquid media. The
aflatoxin inhibitory effect of 16 million V. gazogenes cells was further validated by
UPLC (table 5.2). The ultra HPLC shows the complete loss of aflatoxin B1 and aflatoxin
B2 by A. flavus during V. gazogenes treatments. We also observed the complete loss of
Cyclopiazonic acid (another major mycotoxin belonging to ergoline alkaloids) of A.
flavus during V. gazogenes treatments. Accordingly for further experimentation we
choose to use 16 million V. gazogenes cells.
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5.4.2. V. gazogenes decreases A. flavus aflatoxin production over time
To understand the effect of V. gazogenes on aflatoxin production beyond the
normal 48 h, we treated A. flavus (in YES liquid media) with 16 million V. gazogenes
cells for 72 hours, collecting media and mycelia at 24, 48 and 72 h time points. Dry
weight analysis revealed the no difference in the growth of the fungi between treated and
untreated samples (figure 5.2a) for that specific time point. On the other hand the
aflatoxin analysis revealed that V. gazogenes decreases aflatoxin to undetectable levels
even at 72 h time point (figure 5.2b). The data shows that the aflatoxin inhibitory effect
of V. gazogenes does not stop at the early stationary phase (48 h) where the fungal cells
were thriving but also that the V. gazogenes effectively inhibits aflatoxin when the fungal
cells were over crowded and starting to form a biofilm (72 h).
5.4.3 V. gazogenes aflatoxin inhibitory effect was carried on to the second generation of
A. flavus
The classical potato dextrose agar media was used to study the growth of A. flavus
spores in the presence of V. gazogenes. Two different bacterial cellular concentrations of
4 and 16 million V. gazogenes cells were spread on the agar plate and fungal colony
growth was observed for 9 days. Observation of the growth of fungal biofilm in the
presence of the bacterium tells us that the growth was significantly slower in the
beginning but eventually catches up to the control with no bacteria (figure 5.3a). The
aflatoxin analysis shows the same pattern of aflatoxin inhibition (~75% for 4 million cells
and undetectable levels for 16 million cells) in the presence of V. gazogenes (figure 5.3b).
But surprisingly the spore count for the fungal colony in the presence of 16 million cells
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was >50% as compared to its no bacterial control (figure 5.3c). The gram-negative
bacterium V. gazogenes encourages spore generation in A. flavus.
To test the viability and aflatoxin inhibitory effects of the spores generated in the
presence of V. gazogenes, we collected the spores from bacterial treated (4 and 16 million
cells) fungal colonies and re-plated/inoculated them on fresh PDA plates. We called these
the second-generation spores. The second-generation spores had growth pattern and spore
formation similar to controls (figure 5.3d). The second-generation spores generated from
4 million bacterial cells treated fungi did not carry on the aflatoxin inhibitory
characteristics but the spores generated from the 16 million bacterial cells treated fungi
inhibited aflatoxin by 40% (figure 5.3e). Surprisingly the second-generation spores
carried their aflatoxin inhibition characteristics. This tells us that the V. gazogenes
aflatoxin inhibitory effects can be carried through generations.
5.4.4 Dead V. gazogenes cells inhibit aflatoxin levels in A. flavus
Dead bacterial biomass had proven to be better and safer bioadsorbent for
contaminants in the environment and is much preferred due to lack of nutrients and
cultural conditions (Zeroual et al., 2006). To test the supposition that dead V. gazogenes
cells were equally capable of decreasing aflatoxin levels in A. flavus cultural media, we
boiled the bacteria at 100OC for 10 min in a hot plate to make them unviable. (Bacterial
cells were tested by inoculation into fresh marine broth media and observed for growth
using spectrophotometric analysis over the next 48 h and confirmed the no growth of the
V. gazogenes cells). 4 and 16 million dead V. gazogenes cells were used to treat A. flavus
and the mycelial growth and aflatoxin synthesis were observed. After 48 h the fungal
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mycelial mass did not change (regardless of bacterial cellular concentrations) but the
aflatoxin levels significantly decrease with 16 million dead V. gazogenes cells (figure
5.4) similar to live V. gazogenes cells. The UPLC data in table 5.2 shows that dead V.
gazogenes cells cause complete loss of aflatoxin B1, aflatoxin B2 and cyclopiazonic acid
similar to live V. gazogenes cells. This shows us that the unviable and viable V.
gazogenes cells equally inhibit mycotoxin production.
5.4.5 Aflatoxin inhibition of A. flavus is specific to V. gazogenes
To understand if the aflatoxin inhibitory effect was limited to V. gazogenes, we
treated A. flavus with a gram-positive bacterium, Staphylococcus aureus and a gramnegative bacterium, Escherichia coli and analyzed the fungal growth and aflatoxin levels.
16 million dead bacterial cells were added to A. flavus and the fungus was harvested after
72 h. Dead bacteria cells were used to reduce the pathogenic interaction between the A.
flavus, S. aureus and E. coli. The growth of the A. flavus did not change in the presence
of either S. aureus or E. coli and the aflatoxin levels did not show any significant change
either (figure 5.5). This data points out that there is a high possibility that the aflatoxin
inhibitory effect of V. gazogenes is exclusive to itself.
5.4.6 A. flavus uptake of V. gazogenes
Bacterial-fungal interactions exist via various physical associations. In the
bacterial-fungal biofilms, one form of association is the internalization of bacteria by
fungi altering the fungal physiology (Frey-Klett et al., 2011). V gazogenes synthesizes
prodigiosins, which are red in color giving the bacterial cells a red color. A. flavus
cultures (colorless or white) in YES liquid medium were treated with live V. gazogenes
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(red color) and every 6 h the bacterial presence in YES was observed and recorded using
spectrophotometry reading at 600 nm. We observed that the V. gazogenes optical density
decreased over time and the fungal mycelia turned reddish pink (as attributed to the red
pigment in the bacterial cells). The figure 5.6a shows that over a time period of 42 h the
bacteria were completely depleted from the YES media and the media turned back to its
original yellow. To understand the interactions between A. flavus and V. gazogenes we
fixed A. flavus hyphae in the presence of live V. gazogenes and studied them using a
Leica confocal microscope. At 20x magnification we observed the presence of bacteria
inside the fungal walls (figure 5.6b) confirming the uptake of V. gazogenes by A. flavus
hyphae.
5.4.7 Live V. gazogenes increases aflatoxin biosynthesis pathway genes of A. flavus over
time
Previously, Gummadidala et al (Gummadidala et al, 2016) had shown that V.
gazogenes metabolites decrease aflatoxin biosynthesis by inhibiting the aflatoxin genes.
After understanding the effect of V. gazogenes on growth and aflatoxin production of A.
flavus and observing the uptake of V. gazogenes by A. flavus hyphae, we hypothesized
the aflatoxin inhibitory effect was happening at the transcript level. A quantitative
comparison of transcript accumulation of two aflatoxin genes (nor-1 and ver-1) and the
aflatoxin pathway regulator gene (aflR) was performed. Norsolorinic acid is the first
stable compound in the 17-step aflatoxin biosynthesis pathway, which is synthesized by
the Nor-1 reductase enzyme that is encoded by nor-1 gene (Jiujiang Yu, 2012).
Versicolorin A (VER A) is the last compound synthesized prior to the making of the
intermediates that lead to the final aflatoxin products. VER A is converted to the first
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intermediate by a reductase, Ver-1 that is encoded by ver-1 gene (Jiujiang Yu, 2012). The
aflatoxin biosynthesis genes get activated by 24 h with transcript accumulation at 30 h
and by 40 h the fungus is producing copious amounts of aflatoxin in YES liquid growth
media (Roze et al., 2007a). Thus we choose 24, 30 and 40 h to study the transcripts of
nor-1, ver-1 and aflR genes. The 30 h and 40 h samples were compared to the 24 h
sample of that specific treatment condition to calculate relative fold change in gene
expressions. Figure 5.7 shows 3 graphs of fold change of aflR, nor-1 and ver-1 gene
expressions. The aflR (2-3 fold change), nor-1 (3-7 fold change) and ver-1 (2-9 fold
change) gene expressions of untreated control samples of A. flavus were significantly
upregulated from 24 h to 40 h, which is in accordance with multiple published studies.
The aflR (~7 fold change), nor-1 (~25 fold change) and ver-1 (14-17 fold change) gene
expressions of live V. gazogenes treated samples of A. flavus were significantly
upregulated from 24 h to 40 h as compared to their specific controls. On the contrary the
for the A. flavus treated with dead V. gazogenes cells, aflR, and nor-1 show no significant
change and ver-1 decreased at 30 h and increased at 40 h to reach get back to the regular
levels. The data leads us to hypothesize that the V. gazogenes aflatoxin inhibitory
mechanism is different for live and dead V. gazogenes cells. The compilation of the data
shows that both live and dead V. gazogenes cells decrease aflatoxin but do not inhibit the
aflatoxin pathway genes. This leads to the conclusion that the aflatoxin inhibitory effect
of V. gazogenes was not occurring by regulation of the aflatoxin pathway genes.
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5.4.8 Effect of V. gazogenes on global secondary metabolism regulatory genes of A.
flavus
The two global secondary metabolism regulatory genes laeA and veA have been
found to be involved in regulation of aflatoxin synthesis in A. flavus and the deletion of
these genes leads to complete loss of aflatoxin (Cary et al., 2018). To understand if any of
the upstream positive or negative regulators of aflatoxin pathway were affected we
studied the transcript accumulation of laeA, veA and AtfB in the presence of live/dead V.
gazogenes cells at the 24 h, 30 h and 40 h time points of A. flavus growth (figure 5.8).
The 30 h and 40 h samples were compared to the 24 h sample of that specific treatment
condition. The live V. gazogenes cells inhibit the laeA and increase the veA gene
expressions from a 24 h to 40 h time period, which was opposite to what happened in the
untreated control samples. laeA is a negative regulator of veA (Amaike and Keller 2009)
so its not surprising that one transcript accumulation increases while the other deceases.
The pattern of laeA and veA gene expression was similar during dead V. gazogenes
treatments with increase in their gene expression at 40 h time point. We would like to
point out once again that the pattern of gene expression is not explaining the decrease in
aflatoxin levels. This draws the conclusion that live or dead V. gazogenes aflatoxin
inhibitory effect is not due to regulation of aflatoxin pathway genes or global secondary
metabolite regulatory genes. Rather the bacterial inhibitory effect might be at the cellular
level.
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5.4.9 V. gazogenes was endocytosed into endosomal like compartments by the A. flavus
To understand the effect of V. gazogenes on A. flavus at a cellular level we used
electron microscopy to study the surface (SEM) and inside (TEM) of the fungal hyphae
in the presence of live V. gazogenes cells. The scanning electron microscope (SEM)
pictures in figure 5.9 shows images of the surface of A. flavus hyphae untreated/treated
with live V. gazogenes cells. At 17k magnification the wrinkled effected surface of V.
gazogenes treated hyphae can be appreciated. The SEM magnified image of the treated
hyphae shows the entry of the bacteria (yellow arrows) into the A. flavus probably via
endocytosis like process. The transmission electron microscopy (TEM) pictures in figure
5.10 illustrate cross-sectional images of the A. flavus hypha exposing different internal
cellular structures. The 10k and 20k magnified TEM images show the presence of the V.
gazogenes in endosomal like compartments (white arrows) in the A. flavus hypha.
Similarly uptake of nano particles by fungi also altered the fungal physiology by
decreasing aflatoxin biosynthesis (Mitra et al., 2017). These microscopic images state
that V. gazogenes enter the A. flavus hyphae leading to decrease in aflatoxin biosynthesis.
Therefore we state that the V. gazogenes aflatoxin inhibitory effect was happening at the
cellular level.
5.4.10 Effect of V. gazogenes on SOD genes
Previous studies in our lab support the hypothesis that reactive oxygen species
output is regulated by aflatoxin biosynthesis (Keene et al., 2018). To understand the
cellular processes involved in aflatoxin inhibitory effect of V. gazogenes we studied the
genes involved in reactive oxygen species (ROS) regulation. Superoxide dismutases are
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synthesized in response to reactive oxygen species. We studied the genes MnSOD and
CuZnSOD in the presence of live/dead V. gazogenes cells at the 24 h, 30 h and 40 h time
points of A. flavus growth (figure 5.11). The 30 h and 40 h samples were compared to the
24 h sample of that specific treatment condition. The CuZnSOD gene expression was
decreased as compared to its specific control during both live and dead V. gazogenes
treatments. This is similar to the already existing data stating the decrease in CuZnSOD
from 24 h to 40 h. The MnSOD gene expression increased as compared to its specific
control during both live and dead V. gazogenes treatments following the same pattern as
untreated control samples. The only difference was that in the live V. gazogenes
treatments the increase in MnSOD over time is double as compared to the untreated
controls. Keene et al propose a model for aflatoxin biosynthesis protecting the cells
against the toxic effects of ROS (Keene et al., 2018). Therefore more aflatoxin means
less ROS. Thus the increase in MnSOD in presence of live V. gazogenes cells might be
hypothesized that there might be increased levels of ROS as the aflatoxin levels had been
all but completely inhibited.
5.4.11 V. gazogenes decreases aflatoxin in corn and delays infestation of corn by A.
flavus
A. flavus effects plant health and crop produce by not only producing the
mycotoxin aflatoxin but also by acting as a pathogen. Data already showed the aflatoxin
inhibitory effects of V. gazogenes so now we would like to understand the effects of V.
gazogenes on A. flavus pathogenicity. We pricked corn kernels to mimic insect bites
since it was proved that insect bites make the corn more susceptible to A. flavus
infestations (Cardwell et al., 2000). Three sets of 10-kernels/each set were used and data
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was shown in figure 5.12 where the top panel shows pictures of kernels taken using Leica
dissection microscope. The kernels having no A. flavus or V. gazogenes did not have any
bacterial or fungal contamination. The positive controls for V. gazogenes did not have
any fungal contamination or bacterial infestation suggesting that V. gazogenes might not
be a plant pathogen. The positive controls for A. flavus had plenty of mycelial growth and
spore generation proving the already known fact that A. flavus infests maize. The kernels
treated with live V. gazogenes cells prior to A. flavus infestation showed only 20%
conidial formation, which is almost 80% less than A. flavus positive controls. The
aflatoxin production in the V. gazogenes treated kernels was <98% as compared to the
positive controls. These data show that V. gazogenes has a high possibility to become
anti-A. flavus pesticide for plants.
5.4.12 V. gazogenes increases survival of Drosophila flies infected with A. flavus
Drosophila melanogaster is a well-studied and well-established model organism
for understanding human diseases. Here we used the common fruit fly as a model to
study the effects of V. gazogenes on A. flavus human pathogen. We used atleast 25
flies/tube of 3 sets per condition and data was shown in figure 5.13. Drosophila flies with
no A. flavus or V. gazogenes had survival of 100% at the end of 7 days. Drosophila flies
with only V. gazogenes also had survival of 100% at the end of 7 days suggesting that V.
gazogenes might not be a Drosophila fly pathogen. The positive controls with Drosophila
having infected with only A. flavus had survival of 0 at the end of 8 days since all flies
died. Surprisingly the flies treated with V. gazogenes in their feed and then infected with
A. flavus had survival of 40% at the end of 7 days. Finally we studied the pathogenic
gene SAP (serine alanine protease) since it was considered as a marker for A. flavus
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pathogenicity. In the untreated samples SAP gene expression increased at 40 h but in live
V. gazogenes treated samples the SAP gene expression increase early on at 30 h and
maintain high through 40 h. The dead V. gazogenes cell treatments to not effect SAP
gene expression as compared to their control at 24 h. The data show that V. gazogenes
increase survival in Drosophila during A. flavus infections and the mechanism of action
might not be at the gene level.
5.5 DISCUSSION
This research study shows the discovery of a novel tool (Vibrio gazogenes) to
inhibit aflatoxin production and pathogenicity of human and plant pathogen Aspergillus
flavus. Researchers had previously shown the inhibition of aflatoxin production in A.
flavus or a close sister species A. parasiticus by lactic acid bacteria such as Lactobacillus
casei (Chang and Kim 2007), gram positive bacteria such as Bacillus subtilis (Farzaneh et
al., 2017) and other soil bacteria. Most studies show a decrease in aflatoxin levels and the
mechanism of action of the bacterium was primarily by inhibiting the aflatoxin
biosynthesis pathway genes. Here for the first time we use a marine bacterium V.
gazogenes and the mechanism of aflatoxin inhibition was not at the gene level (we
observe an increase in aflatoxin and secondary metabolite regulatory genes) but at the
cellular level thereby breaking the previously established paradigm.
Both viable and unviable V. gazogenes cells inhibition of aflatoxin is >98% with
out effecting the growth of A. flavus in both solid and liquid growth medium. On the
other hand live V. gazogenes cells significantly increase spore production of A. flavus on
classical potato dextrose media. Spores are the means by which the fungi disperse and
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find new and favorable environment to grow and flourish on. The second-generation
spores generated due to A. flavus treatment with V. gazogenes carried over the aflatoxin
inhibition properties and consequently decreased aflatoxin by 40%. It is new to know that
the V. gazogenes aflatoxin inhibitory effects can transcend generations.
The gene data of A. flavus of various genes up- and down- regulated in the
presence of live and dead V. gazogenes does not follow the same pattern. This leads us to
conclude that live and dead V. gazogenes cells do not follow the same mechanism of
aflatoxin inhibition in A. flavus. V. gazogenes were made nonviable or dead by heating
which causes protein denaturation but might not break the structural integrity of the
peptidoglycan structure of the bacterial cell wall (Carolyn A. Haskard, et al., 2001).
Lactic acid bacteria made nonviable by heating effectively removed aflatoxin B1 from
the media suggesting binding rather than metabolism (Carolyn A. Haskard et al., 2001).
Therefore the dead V. gazogenes might be removing aflatoxin from media via cell wall
binding.
The aflatoxin inhibition by live V. gazogenes was through the uptake of the live
bacterium by fungus into endosomal like compartments, which we had observed using
confocal, SEM and TEM microscopies. Previously published data show the
internalization of the bacteria via endocytosis like mechanism (Guerra-Tschuschke et al.,
1991). Anindya et al isolated protoplasts and performed feeding experiments concluding
that aflatoxin synthesis was happening in vesicles termed aflatoxisomes, which are
endosomal like compartments (Chanda et al., 2009). Thus we suggest that live V.
gazogenes cells were entering the A. flavus through endocytosis like mechanism (into
endocytosis like compartments) probably into the aflatoxisomes (that contains all the
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enzymes required for aflatoxin synthesis) and inhibiting the aflatoxin biosynthesis at the
cellular level. Researchers propose that during the fungal growth, a shift in the media
components might activate the hydrolase and laccase enzymes, which have the capacity
to degrade the lactone ring of the aflatoxin (Fatemeh Siahmoshteh et al., 2016).
Considering the existing data we hypothesize that live V. gazogenes cells might be
degrading the aflatoxin in the aflatoxisome. Since there was no aflatoxin released into the
growth media during live V. gazogenes treatments (undetected using ELISA) but an
increase in aflatoxin pathway genes was observed we predict that the fungal cells were
making increased transcript to generate more aflatoxin in the fungal cells.
The relationship between the live V. gazogenes and A. flavus is not conclusive
from the data obtained. Further experimentation is required to determine the symbiotic
relationship’s existence and nature between the two microorganisms. We do not yet know
if the bacterium is still viable inside the fungus. Bacteria are hard to kill and as such there
is a strong possibility for bacterial-fungal interaction within the fungal cell.
Understanding the mechanism by which V. gazogenes decreases aflatoxin and
inhibits pathogenicity of A. flavus will help us further understand how to develop, design
and target A. flavus pathogen and decrease mortality rates of fungal infected patients and
plants. This research establishes a novel concept for combating Aspergillosis infections
that are very common in homes impacted by weather events such as hurricanes and are
common in immunocompromised individuals (Krishnan et al., 2009). Finally
polymicrobial (bacterial and fungal) colonies pose a potential problem in clinical setting
given their multi-drug resistance capabilities. This study has initiated a novel research
direction that can elucidate the molecular details that regulate bacterial uptake in fungal
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pathogens. Such interactions are critical in designing probiotic supplements for
preventing release of virulence factors and secondary metabolites that are key in fungal
pathogenesis.
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Table 5.1: List of primers used in this study.

Genes

Primer Sequences

aflR

F 5’-ACCTCATGCTCATACCGAGG-3’
R 5’-GAAGACAGGGTGCTTTGCTC-3’

nor-1

F 5’-CACTTAGCCAGCACGATCAA-3’
R 5’-ATGATCATCCGACTGCCTTC-3’

ver-1

F 5’-AACACTCGTGGCCAGTTCTT-3’
R 5’-ATATACTCCCGCGACACAGC-3’

AtfB

F 5’-CCGGTTTCGTGAGGTATCCA-3’
R 5’-GCATGGGAGAAACCAGATCG-3’

laeA

F 5’-ATGGGGTGTGGAAGTGTGAT-3’
R 5’-ATCGGTAAAACCAGCCTCCT-3’

veA

F 5’-TCCAGCTATCCCAAGAATGG-3’
R 5’-TAATCCCCCGATAGAGCCTT-3’

MnSOD

F 5’-CCACATCAACCACTCCCTCT-3’
R 5’-TCCTGATCCTTCGTCGAAAC-3’

CuZnSOD-1

F 5’-CACCAGTTCGGTGACAACAC-3’
R 5’-GTGTTCACTACGGCCAAGGT-3’

18s

F 5’-GCTGAAAACCTCGACTTCGG-3’
R 5’-CCTAATTCCCCGTTACCCGT-3’

Tubulin

F 5’-TCTCCAAGATCCGTGAGGAG-3’
R 5’-TTCAGGTCACCGTAAGAGGG-3’

SAP

F 5’-GAATTCTCGTGGACGTAGCG-3’
R 5’-GACGTCGGTCCTTCTTCTCC-3’
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Table 5.2: Data of Aflatoxin B1, Aflatoxin B2 and Cyclopiazonic acid obtained from
UPLC

Sample

Aflatoxin B1
ppb (ng/g mycelia)

Aflatoxin B2
ppb (ng/g mycelia)

Cyclopiazonic acid
ppb (ng/g mycelia)

A. flavus
(no V. gazogenes)

24.51

3.27

7298.41

A. flavus + 16 million
live V. gazogenes
cells

0

0

0

A. flavus + 16 million
dead V. gazogenes
cells

0

0

0
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Figure 5.1: Effect of V. gazogenes on aflatoxin biosynthesis and growth of A. flavus
mycelial growth: a) & b) A. flavus co-cultured with 4 and 16 million V. gazogenes cells in
YES liquid media and the dry weight of fungal mycelia was measured and aflatoxin
levels analyzed after 48 h of incubation. The percentage of A. flavus mycelial weight was
calculated and plotted on y-axis. Bars represent measurements relative to the dry weight
of untreated (a). Percent aflatoxin accumulation in media of 48 h cultures (b). p-value
<0.01 and n=3 c)&d) A. flavus co-cultured with V. gazogenes on YES agar media plates
and the colony growth was measured and the aflatoxin was analyzed after 9 days of
incubation. The growth of fungal colony in cm was measured and plotted on y-axis (c)
(n=2). Percent aflatoxin accumulation in agar media of the fungal colonies was plotted
(d) (n=4). p-value <0.01. Statistical significance of two-tailed p-values were determined
using an unpaired t-test. Error-bars represent SEM. Star indicates significance.

92

Figure 5.2: Effect of V. gazogenes on A. flavus aflatoxin production over time: A. flavus
was co-cultured with 16 million V. gazogenes cells in YES liquid media and the mycelial
growth of fungus was calculated and aflatoxin analyzed at 24, 48 and 72 h. a) Dry weight
of mycelia was plotted on y-axis and bars represent the measurements in grams. b)
Percentage of aflatoxin was plotted on y-axis considering no treated (C) 72 h control
aflatoxin levels as 100% and the aflatoxin in rest of samples plotted relative to the 72 h C.
Insert shows the accumulation of aflatoxin at 48 h. p-value <0.01. Statistical significance
of two-tailed p-values were determined using an unpaired t-test for n=3. Error-bars
represent SEM. Star indicates significance.
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Figure 5.3: A) Effect of V. gazogenes on A. flavus spore generation: A. flavus was cocultured with V. gazogenes on 10cm PDA media plates and the colony growth was
measured and the aflatoxin was analyzed after 9 days of incubation. i) The growth of
fungal colony in cm was measured and plotted on y-axis. ii) The bars represent percent
aflatoxin accumulation in agar media of the fungal colonies as compared to the untreated
control. iii) Percent of spores per colony was counted and plotted with the bars
representing the number of spores as compared to the untreated control (n=4). B) Activity
of second-generation A. flavus spores. Spores generated from bacterial treatment were replated on fresh PDA plates (without V. gazogenes) and colony growth was observed for 9
days. i) The growth of fungal colony in cm was measured and plotted on y-axis. ii) The
bars represent percent aflatoxin accumulation in agar media of the fungal colonies as
compared to the untreated control. iii) Percent of spores per colony was counted and
plotted with the bars representing the number of spores as compared to the untreated
control (n=2). Statistical significance of two-tailed p-values were determined using an
unpaired t-test. Error-bars represent SEM. Star indicates significance.
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Figure 5.4: Effect of dead V. gazogenes cells on A. flavus growth and aflatoxin
production: A. flavus co-cultured with dead 4 and 16 million V. gazogenes cells in YES
liquid media and the dry weight of fungal mycelia was measured and aflatoxin levels
analyzed after 48 h of incubation. a) The percentage of A. flavus mycelial weight was
calculated and plotted on y-axis. Bars represent measurements relative to the dry weight
of untreated. b) Percent aflatoxin accumulation in media of 48 h cultures. p-value <0.01
and n=2. Statistical significance of two-tailed p-values were determined using an
unpaired t-test for n=3. Error-bars represent SEM. Star indicates significance.
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Figure 5.5: Effect of dead S. aureus and E. coli on A. flavus growth and aflatoxin
production: A. flavus co-cultured with dead 16 million S. aureus and E. coli cells in YES
liquid media and the dry weight of fungal mycelia was measured and aflatoxin levels
analyzed after 72 h of incubation. a) The percentage of A. flavus mycelial weight was
calculated and plotted on y-axis. Bars represent measurements relative to the dry weight
of untreated. b) Percent aflatoxin accumulation in media of 48 h cultures. p-value <0.01
and n=2. Statistical significance of two-tailed p-values were determined using an
unpaired t-test for n=2 revealing that there was no statistical difference between control
and treated samples. Error-bars represent SEM.
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Figure 5.6: Uptake of V. gazogenes by A. flavus: a) V. gazogenes and A. flavus were cocultured in YES liquid media. Every 6 h the OD of the bacteria at 600 nm was measured
and plotted on y-axis with incubation time in the x-axis (n=3). b) The confocal
microscopy of A. flavus hyphae in the presence of V. gazogenes at 20x magnification.
This is a representation of n=3 experiments.
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Figure 5.7: V. gazogenes increases aflatoxin pathway genes: Quantitative PCR (qPCR)
comparison of aflatoxin pathway gene (aflR, nor-1, ver-1) expressions in A. flavus during
the two treatment conditions of live and dead V. gazogenes at 24 h, 30 h and 40 h time
points of culture growth. Each individual gene expression was normalized to the
housekeeping gene 18s which was used as reference gene. The 30 h and 40 h samples
were compared to the 24 h sample of that specific treatment condition to calculate
relative fold change in gene expressions. Fold changes ≥2.0 with p-value <0.01 were
considered significantly up or down regulated. Star indicates statistically significant fold
change as compared to the 24 h control of that specific treatment.
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Figure 5.8: V. gazogenes increases global secondary metabolite regulatory genes:
Quantitative PCR (qPCR) comparison of global secondary metabolite regulate (AtfB,
laeA, veA) gene expression in A. flavus during the two treatment condition of live and
dead V. gazogenes at 24 h, 30 h and 40 h time points of culture growth. Each individual
gene expression was normalized to the housekeeping gene 18s which was used as
reference gene. The 30 h and 40 h samples were compared to the 24 h sample of that
specific treatment condition to calculate relative fold change in gene expressions. Fold
changes ≥2.0 with p-value <0.01 were considered significantly up or down regulated.
Star indicates statistically significant fold change as compared to the 24 h control of that
specific treatment.
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Figure 5.9: Scanning electron microscopy of A. flavus uptake of V. gazogenes: Scanning
electron microscopy of A. flavus hyphae treated with V. gazogenes at 17k magnification.
The top left image is of control hypha and the left bottom image is of A. flavus in
presence of V. gazogenes. The magnified image is of a hypha with arrows pointing to the
bacteria being endocytosed. The scale is 5 µm.
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Figure 5.10: Transmission electron microscopy of A. flavus uptake of V. gazogenes:
Transmission electron microscope’s cross sectional images of untreated control A. flavus
hyphae (top images) and V. gazogenes treated hyphae (bottom images) with 10k
magnification (left images) and 20k magnification (right images). The arrows point to
endosomal compartments. This is a representation of n=3 experiments.
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Figure 5.11: V. gazogenes increases SOD genes: Quantitative PCR (qPCR) comparison
of SOD gene expression in A. flavus during the two treatment condition of live and dead
V. gazogenes at 24 h, 30 h and 40 h time points of culture growth. Each individual gene
expression was normalized to the housekeeping gene 18s which was used as reference
gene. The 30 h and 40 h samples were compared to the 24 h sample of that specific
treatment condition to calculate relative fold change in gene expressions. Fold changes
≥2.0 with p-value <0.01 were considered significantly up or down regulated. Star
indicates statistically significant fold change as compared to the 24 h control of that
specific treatment.
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Figure 5.12: Effect of V. gazogenes on corn infestation of A. flavus: Packaged corn
kernels were used with 10-kernels/treatment set and the sets were done in triplicate.
Control (C) was a negative control with no A. flavus or V. gazogenes. V. gazogenes (Vg)
was a positive control for the bacteria having only V. gazogenes. A. flavus (Af) was a
positive control for the fungus having only A. flavus. A. flavus + V. gazogenes (Af+Vg)
was the treatment condition where kernel was infested with A. flavus in the presence of V.
gazogenes. a) The top panel shows images taken using Leica dissection microscope on
the 5th day on incubation. b) The graph represents the percent of conidia/spores formation
on the corn kernels in the presence and absence of V. gazogenes during A. flavus
infestation. c) The bars represent the percentage of aflatoxin present in the kernels as
compared to the A. flavus positive control (Af). p-value <0.01. Statistical significance of
two-tailed p-values were determined using an unpaired t-test for n=3. Error-bars represent
SEM. Star represents the difference as compared to the control was statistically
significant.
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Figure 5.13: Effect of V. gazogenes on Drosophila infection by A. flavus: a) Drosophila
melanogaster flies were infected with A. flavus in the absence (Af) and presence (Af+Vg)
of live V. gazogenes cells. We used 3-5 day old female flies, 25 flies/tube (for Af) and 29
flies/tube (for Af+Vg) in sets of 3 (method was describes earlier). The percentage of flies
survived per day per tube was calculated and plotted as a line graph. b) Quantitative PCR
(qPCR) comparison of SAP (pathogenic gene) gene expression in A. flavus during the
two treatment 2condition of live and dead V. gazogenes at 24 h, 30 h and 40 h time points
of culture growth. The gene expression was normalized to the housekeeping gene 18s
which was used as reference gene. The 30 h and 40 h samples were compared to the 24 h
sample of that specific treatment condition to calculate relative fold change in gene
expressions. Fold changes ≥2.0 with p-value <0.01 were considered significantly up or
down regulated. Star indicates statistically significant fold change as compared to the 24
h control of that specific treatment.
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